Student list for M.Pharm Sem 4 (Regular) Dissertation Phase ...

Sr.

No.Date MAP_NUMBER Student_name sub code

Branch_

Code

College

_Code

Branch_

TypeBranch_name Micro

Other_

MicroDP1_TITLE Guide Name

1 01-May-2019 172390820004 CHIRAG NATUBHAI PATEL MRW403P 20 239 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,

TOPICAL, HYDROGELS NASAL

DESIGN AND CHARACTERIZATION OF TRANSDERMAL

PATCH OF VENLAFAXINE HYDROCHLORIDEDR. HITESH DALVADI

2 01-May-2019 172390820009 Patel Kinjal Ishwarbhai MRW403P 20 239 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DESIGN & OPTIMIZATION OF INTRANASAL DRUG

DELIVERY(SPRAY) OF QUETIAPINE FUMARATEDR. HITESH DALVADI

3 01-May-2019 172390820010 SIDDIKI DOLLY SAFIULREHMAN MRW403P 20 239 MP Pharmaceutics FORMULATION, EVALUATION AND OPTIMIZATION OF

MICROEMULSION BASED HYDROGEL OF TOLNAFTATEDR. HITESH DALVADI

4 01-May-2019 172540820002 Gangat Asma Abdulsattar MRW403P 20 254 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FABRICATION AND CHARACTERIZATION OF LULICONAZOLE

FILM-FORMING TOPICAL SPRAY FOR THE TREATMENT OF

FUNGAL INFECTION

DR. BHAVESH AKBARI

5 01-May-2019 172650820001 BARIA ROHANKUMAR PANKAJKUMAR MRW403P 20 265 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION DEVELOPMENT AND EVALUATION OF

MATRIX TABLETS OF DARIFENACIN HYDROBROMIDEMRS.ANKITA J.PATEL

6 01-May-2019 172650820005 KANZARIA JALPA HASMUKHBHAI MRW403P 20 265 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,



NASAL IN SITU GEL OF ANTIEPILEPTIC DRUGDR. ANURADHA PRAJAPATI

7 02-May-2019 172450829001 Chaudhary Rajat b MRW403P 29 245 MP Clinical Pharmacy BABE STUDYA RANDOMIZED DOUBLE BLINDED, CROSS-OVER

BIOEQUIVALENCE STUDY OF FELODIPINE EXTENDED DR. I. S. ANAND

8 02-May-2019 172450829002 Chaudhary Shefali Jayantibhai MRW403P 29 245 MP Clinical Pharmacy OTHER (KINDLY SPECIFY)STUDY ON PRESCRIBING PATTERN OF ANTIBIOTICS IN

PATIENTS ADMITTED TO INTENSIVE CARE UNITSDR. I. S. ANAND

9 02-May-2019 172450829003 Chaudhary Sumanben Rameshbhai MRW403P 29 245 MP Clinical Pharmacy BABE STUDY

A RANDOMIZED CROSS-OVER BIOEQUIVALENCE STUDY OF

METOPROLOL SUCCINATE EXTENDED RELEASE (200 MG)

TABLET UNDER FASTING CONDITION

DR. I. S. ANAND

10 02-May-2019 172820829002 MONA HITESHKUMAR SUTHAR MRW403P 29 282 MP Clinical Pharmacy OTHER (KINDLY SPECIFY)

EVALUATION OF RATIONALITY OF ANTIMICROBIAL AND

ANTIDIARRHEAL FIX DOSE COMBINATION USED IN INDIAN

POPLUTION

DR. HETAL D. SOLANKI

11 02-May-2019 172820829003 PARMAR HEMAKSHIBEN RAMANBHAI MRW403P 29 282 MP Clinical Pharmacy OTHER (KINDLY SPECIFY)

KNOWLEDGE AND PRACTICES OF ANTIBIOTICS SELF-

MEDICATION AMONG HEALTHCARE PROFESSIONAL

STUDENTS IN GUJARAT

DR. HETAL D. SOLANKI

12 25-April-2019 172060820002 MALAVIYA VIKASKUMAR MADHUBHAI MRW403P 20 206 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


ONDANSETRON HCL EXTENDED RELEASE TABLETDR. MITTAL MAHESHWARI

13 25-April-2019 172080820003 PATEL DHRUV JAYNESHKUMAR MRW403P 20 208 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF FIXED DOSE GASTRO-

RETENTIVE BILAYER TABLET CONTAINING METFORMIN AS DR. UPENDRA L PATEL

14 25-April-2019 172280820001 BHAVSAR JAINI PANKAJKUMAR MRW403P 20 228 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION, DEVELOPMENT AND EVALUATION OF

CONTROLLED RELEASE TABLET OF TENELIGLIPTIN

HYDROBROMIDE HYDRATE

DR. YAMINI SHAH

15 25-April-2019 172280820009 Shah Pahini Jigarbhai MRW403P 20 228 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION, OPTIMIZATION AND EVALUATION OF

CONTROLLED RELEASE TABLETS OF LORCASERIN

HYDROCHLORIDE

DR. MANISH P. PATEL

16 25-April-2019 172420820002 Parekh Aarti Jayprakash MRW403P 20 242 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT & EVALUATION OF GASTRO RETENTIVE

FLOATING TABLETS FOR ORAL DRUG DELIVERY OF

ENTACOPONE

DR DHAVAL J PATEL

GTU/S19/DP-2/MPH-3074 Date:- 20-04-2019

Student list for M.Pharm Sem 4 (Regular) Dissertation Phase-2 (DP-2) (Summer 2019)Gujarat Technological University

17 25-April-2019 172600820001 ANKIT SINGH KUSHWAH MRW403P 20 260 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT, OPTIMIZATION AND EVALUATION OF

EXTENDED RELEASE TABLET OF PALIPERIDONEDR. KUNAL N. PATEL

18 25-April-2019 172620820002 PARMAR MADHAVSINH VIJAYBHAI MRW403P 20 262 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND CHARACTERIZATION OF MOUTH

DISSOLVING TABLETS OF VILAZODONE HCL PROF. RAVI V. PATEL

19 25-April-2019 172620820004 PRAJAPATI RINKUBEN ASHOKBHAI MRW403P 20 262 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND OPTIMIZATION OF SUSTAINED

RELEASE DRUG DELIVERY SYSTEM OF SOFOSBUVIR PROF. BHUMI RAVAL

20 26-April-2019 172070820002 PANDYA KHYATIBEN NITINKUMAR MRW403P 20 207 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


“FORMULATION AND EVALUTION OF BILAYERED BUCCAL

TABLET OF IVABRADINE HYDROCHLORIDE”DR. VISHNU M. PATEL

21 26-April-2019 172070820003 patel yaminibahen nikhilkumar MRW403P 20 207 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


“FORMULATION AND EVALUTION OF BUCCAL PATCH

CONTAINING DULOXETINE HYDROCHLORIDE FOR THE

TREATMENT OF DEPRESSION’’

DR. VISHNU M. PATEL

22 26-April-2019 172250820003 Patel Bhaveshkumar Amrutlal MRW403P 20 225 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF BUCCAL FILMS OF

PIRIBEDILDR. SHAILESH T. PRAJAPATI

23 26-April-2019 172250820006 PATEL RAJAT BHARATBHAI MRW403P 20 225 MP Pharmaceutics MULTIPARTICULATEFORMULATION AND EVALUATION OF SUSTAINED RELEASE

MICROSPHERES OF ITOPRIDE HYDROCHLORIDE DR. KEYUR S. PATEL

24 26-April-2019 172470820009 PANDIT VIPULKUMAR DINESHKUMAR MRW403P 20 247 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF BUCCAL FILMS OF

SAXAGLIPTINMR. VIJAY K. PATEL

25 26-April-2019 172780820005 SOLANKI ARTI NARENDRASINH MRW403P 20 278 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,



BUCCAL TABLETS OF ZOLPIDEM TARTRATEDR. KINJAL SOLANKI

26 26-April-2019 162470808006 PATEL VIJAYKUMAR JAYANTIBHAI 940102 08 247 MP PHARMACEUTICSIR, ODT, DT, SUBLINGUAL, FAST

DISPERSIBLE/DISSOLVING

FORMULATION AND EVALUATION OF SUSTAINED RELEASE

MATRIX TABLETS OF PRAZOSIN HYDROCHLORIDEMR.ANIL RAVAL

27 29-April-2019 172020820002 Vashi Janu Alkeshkumar MRW403P 20 202 MP Pharmaceutics MULTIPARTICULATE

FORMULATION AND OPTIMIZATION OF ILEO-COLONIC

TARGETED MUCOADHESIVE MICROSPHERES CONTAINING

FLURBIPROFEN FOR TREATMENT OF ULCERATIVE COLITIS

DR. SAIKAT PANDE

28 29-April-2019 172050820001 Joshi Deepika Manohar MRW403P 20 205 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FABRICATION AND IN VITRO EVALUATION OF FEBUXOSTAT

TABLET FOR OBTAINING BIPHASIC DRUG RELEASE PROFILEDR. MUKESH GOHEL

29 29-April-2019 172050820005 PATEL KAJOLBEN ARUNKUMAR MRW403P 20 205 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


PREPARATION AND CHARACTERIZATION OF TOPICAL

FORMULATION CONTAINING QUERCETIN AS WOUND

HEALING PHYTOPHARMACEUTICAL

DR. VAISHALI THAKKAR

30 29-April-2019 172050820009 Udhwani Nikita Haresh MRW403P 20 205 MP Pharmaceutics MULTIPARTICULATE

EXPLORATION OF RESEARCH OPPORTUNITIES IN THE

DEVELOPMENT OF IMMEDIATE RELEASE MINI-TABLETS OF

CILOSTAZOL

DR. MUKESH C. GOHEL

31 29-April-2019 172050820010 Vyas Shubham Sanjaykumar MRW403P 20 205 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DEVELOPMENT AND CHARACTERIZATION OF

ROXITHROMYCIN TOPICAL GELDR. VAISHLAI THAKKAR

32 29-April-2019 172130820007 SHAH HARDIK SANJAYKUMAR MRW403P 20 213 MP PharmaceuticsVESICULAR DRUG DELIVERY

SYSTEM

DEPOFOAM TECHNOLOGY BASED INTRAMUSCULAR DRUG

DELIVERY OF PREDNISOLONE ACETATE FOR TREATMENT OF DR.PRACHI PANDEY

33 29-April-2019 172230828002 KAPADIA DHWANI PREYAS MRW403P 28 223 MPPharmaceutical

Technology

BUCO/MUCOADHESIVE, TDDS,


FORMULATION AND CHARACTERIZATION OF LIPOSOME

BASED INTRA-NASAL DELIVERY OF ARIPIPRAZOLE

DR. ALIASGAR J

KUNDAWALA

34 30-April-2019 172120820002 BHATT UKTI JANAKBHAI MRW403P 20 212 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

STUDIES IN APPLICATION OF HOT MELT EXTRUSION

TECHNIQUE FOR DEVELOPMENT OF DELAYED RELEASE

FENOFIBRATE WITH IMPROVED DISSOLUTION.

DR S R SHAH

35 30-April-2019 172120820005 CHUDASAMA TARUN RAMESHBHAI MRW403P 20 212 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF EXTENDED RELEASE

TABLET OF NIACIN.DR J R CHAVDA

36 30-April-2019 172120820006 GELHOR HIMANI BABUBHAI MRW403P 20 212 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


FLOATING TABLET OF CINNARIZINE.DR D R BHIMANI

37 30-April-2019 172690820001 Bhuva Mitalben Dineshbhai MRW403P 20 269 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DESIGN, FORMULATION AND EVALUATION OF PRESS

COATED PULSATILE DRUG DELIVERY SYSTEM OF

AZILSARTAN MEDOXOMIL TABLET

MISS. SHEETAL

BUDDHADEV

38 30-April-2019 172690820004 Raninga Tushar Kishorbhai MRW403P 20 269 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DESIGN, DEVELOPMENT AND EVALUTION OF BILAYER

TABLET OF PIOGLITAZONE AND PHENFORMIN FOR

EXTENDED RELEASE SYSTEM

SHEETAL BUDDHADEV

39 01-May-2019 172150820001 HITESH SANJAY BAKAS MRW403P 20 215 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND DEVELOPMENT OF RAFT FORMING

FLOATING DRUG DELIVERY SYSTEM FOR DOMPERIDONE

SUSTAIN DRUG RELEASE

MR VINOD RAMANI

40 01-May-2019 172150820002 PARMAR HIRENKUMAR NARANBHAI MRW403P 20 215 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

To Study the effect of hydro-alcoholic media on drug

release behavior of extended release tablet containing

metoprolol

MR VINOD RAMANI

41 01-May-2019 172150820004 YADAV AJAY CHHOTELAL MRW403P 20 215 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND DEVELOPMENT OF IN SITU GEL

CONTAINING LEVOFLOXACIN LOADED LIPOSOME FOR

PERIODONTITIS

MR. R. SENTHIL KUMAR

42 01-May-2019 172390820002 BHANDARI RINAL HASMUKHRAI MRW403P 20 239 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION, EVALUATION AND OPTIMIZATION OF IN-

SITU NASAL GEL OF FROVATRIPTAN SUCCINATEMR. TULARAM BAROT

43 01-May-2019 172390820005 HALPATI DARSHITA UMESH MRW403P 20 239 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT AND EVALUATION OF NANOPARTICLE

BASED IN-SITU GEL OF LOTEPREDNOL ETABONATEDR. HITESH DALVADI

44 01-May-2019 172390820012 SINGH SHOBHA DESHRAJ MRW403P 20 239 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND DEVELOPMENT OF IN-SITU GEL FOR

OCULAR DRUG DELIVERY OF TRAVOPROSTDR. KOMAL PARMAR

45 01-May-2019 172650820008 PATEL MANSVIBEN SURESHBHAI MRW403P 20 265 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


EXTENDED RELEASE DRUG DELIVERY SYSTEM OF

LUBIPROSTONE

MR. AJAY TALELE

46 02-May-2019 172020826001 PATEL KAJAL DHANJIBHAI MRW403P 26 202 MP Pharmacognosy HERBAL RESEARCHPHARMACOGNOSTICAL, PHYTOCHEMICAL AND DIURETIC

ACTIVITY OF RORIPPA INDICADR.(MRS) MONA KUKKAR

47 25-April-2019 172080820001 BHATT VIBHUTI DHIRENKUMAR MRW403P 20 208 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST

DISPERSIBLE/DISSOLVISTUDY ON DISSOLUTION ENHANCEMENT OF EZETIMIBE DR. DASHRATH PATEL

48 25-April-2019 172280820005 NAMIT GUPTA MRW403P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST

DISPERSIBLE/DISSOLVI

MOUTH DISSOLVING FILMS OF NARATRIPTAN

HYDROCHLORIDEDR. MANISH P. PATEL

49 25-April-2019 172280820007 Patel Het Suryakantbhai MRW403P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



ORAL DOSAGE FORM OF RISEDRONATE SODIUMDR. PRAFUL BHARADIA

50 25-April-2019 172420820004 Patel Parth Laxmanbhai MRW403P 20 242 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF GASTRIC FLOATING

TABLETS CONTAINING CAPTOPRIL AND

HYDROCHLOROTHIAZIDE

DR S.K.SHAH

51 25-April-2019 172420820005 PATEL PRIYANK MUKESHBHAI MRW403P 20 242 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND IN-VITRO DISSOLUTION

ENHANCEMENT OF BLONANSERIN USING LIQUISOLID

COMPACTS

DR SANJESH G RATHI

52 25-April-2019 172600820004 PATEL KRUSHIKA JAGDISHKUMAR MRW403P 20 260 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF MOUTH DISSOLVING

FILM OF FEXOFENADINE HYDROCHLORIDEDR. KUNAL N. PATEL

53 25-April-2019 172620820005 SHAH AMIBEN MAHESHKUMAR MRW403P 20 262 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND CHARACTERIZATION OF FAST

DISSOLVING TABLETS OF LINAGLIPTIN- AN ANTI-DIABETIC

AGENT

PROF. SURAJ R. CHAUHAN

54 25-April-2019 172620820006 SHUKLA ABHAYKUMAR SANTOSH MRW403P 20 262 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND OPTIMIZATION OF ORAL

DISINTEGRATING STRIPS OF TENELIGLIPTIN FOR THE

TREATMENT OF TYPE II DIABETES

PROF. RAVI V. PATEL

55 26-April-2019 172450820001 Chaudhary Jigneshkumar Ishwarbhai MRW403P 20 245 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND OPTIMIZATION OF ORODISPERSIBLE

TABLET OF A SELECTIVE ALPHA ADRENERGIC BLOCKING

AGENT USING NEFTOPIDIL

DR. H.D.KAREN

56 26-April-2019 172470820002 GAJERA KAUSHIKBHAI GHANSHYAMBHAI MRW403P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF ORODISPERSIBLE

TABLETS OF PALIPERIDONEMR. ANIL G. RAVAL

57 26-April-2019 172470820003 JOSHI ARJUN LALITBHAI MRW403P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF SUBLINGUAL FILMS

OF APIXABANDR. YOGESH K. PATEL

58 26-April-2019 172470820007 MEHTA HIR RAJIV KUMAR MRW403P 20 247 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


GASTRORETENTIVE FLOATING FILMS OF LAFUTIDINEMR. VIJAY K. PATEL

59 26-April-2019 172470820012 SHAH AKASHKUMAR NARESHKUMAR MRW403P 20 247 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF COLON TARGETED

PELLETS OF BUMADIZONE CALCIUMMR. ANIL G. RAVAL

60 26-April-2019 172780820001 DALBANJAN NIKITA SURESHBHAI MRW403P 20 278 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



TABLETS OF TELMISARTANDR. VIKRAM PANDYA

61 26-April-2019 172780820003 PANDIT MRUGESH SURESHBHAI MRW403P 20 278 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF FAST DISSOLVING

FILMS OF LINAGLIPTINDR. VIKRAM PANDYA

62 29-April-2019 172020820001PATEL VISHAKHAKUMARI

MAHESHKUMARMRW403P 20 202 MP Pharmaceutics

NANO SUSPENSION/EMULSION,

SEDDS, LIPID BASED DDS

SOLID SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM: A

NOVEL APPROACH FOR THE ORAL ADMINISTRATION OF

POORLY WATER SOLUBLE DRUG

DR. AJAY SOLANKI

63 29-April-2019 172050820002 MALAV RUPESH MANIAR MRW403P 20 205 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE EXCIPIENTS AND

AT

DEVELOPMENT, CHARACTERIZATION AND EVALUATION OF

DIBASIC CALCIUM PHOSPHATE DIHYDRATE FOR THE

FORMULATION OF SOLID ORAL DOSAGE FORM

DR. MUKESH GOHEL

64 29-April-2019 172050820011 MS. PAROMITA SAHA MRW403P 20 205 MP Pharmaceutics

CO PROCESSED, DC,


AT

MINIMIZATION OF RETARDATION OF DRUG RELEASE FROM

HARD GELATIN CAPSULE DR. MUKESH C. GOHEL

65 29-April-2019 172130820004 PATEL DHRUVI KAMLESHBHAI MRW403P 20 213 MP Pharmaceutics

CO PROCESSED, DC,


AT

PREPARATION AND CHARACTERIZATION OF SPRAY DRIED

SOLID DISPERSION OF AN ANTI-DIABETIC DRUG FOR

DISSOLUTION ENHANCEMENT

DR. NAAZNEEN SURTI

66 29-April-2019 172350820001 Bariya Hiralbhai Ranchhodbhai MRW403P 20 235 MP PharmaceuticsCO PROCESSED, DC,


FORMULATION DEVELOPMENT AND CHARACTERIZATION

OF DIRECTLY COMPRESSIBLE TABLETS OF NISOLDIPINE DR. HITESH JAIN

67 29-April-2019 172350820002 Dindod Swetalben Babubhai MRW403P 20 235 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DESIGN AND CHARACTERIZATION OF MICROSPONGE

LOADED TOPICAL GEL OF LULICONAZOLEDR. HITESH JAIN

68 29-April-2019 172350820003 NEHATE SHWETA BHAGWAN MRW403P 20 235 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION DEVELOPMENT AND OPTIMIZATION OF

MUCOADHESIVE IN SITU NASAL GEL CONTAINING

MONTELUKAST SODIUM

DR. HITESH JAIN

69 30-April-2019 172120820003 BHOLA JAYDIPKUMAR HAJABHAI MRW403P 20 212 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


LIQUISOLID TABLET OF EFAVIRENZ FOR IMPROVING

DISSOLUTION CHARACTERISTICS: DESIGN, DEVELOPMENT

AND OPTIMIZATION

DR. M. M. SONIWALA

70 30-April-2019 172120820010 PATEL JETALBEN VASANTBHAI MRW403P 20 212 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


MEDICATED CHOCOLATE CONTAINING CEFIXIME

TRIHYDRATE: A NOVEL SOLID DOSAGE FORM FOR K A PATEL

71 30-April-2019 172640820003 GADHVI SIDDHI SANJAYDAN MRW403P 20 264 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF ORO DISPERSIBLE

TABLETS OF ONDANSETRON HYDROCHLORIDE

MS. DHARMISHTHA A.

MOVALIA

72 30-April-2019 142240808013 PATEL VIVEK GANPATBHAI 940102 08 224 MP PHARMACEUTICSIR, ODT, DT, SUBLINGUAL, FAST



FILM OF ENALAPRIL MALEATEMRS SEJAL SOLANKI

73 01-May-2019 172390820001 BEHERA SHREEKANT SHIVRAM MRW403P 20 239 MP Pharmaceutics OTHER (KINDLY SPECIFY)

FORMULATION AND DEVELOPMENT OF POLYMERIC

MICELLE FOR DISSOLUTION ENHANCEMENT OF

EXEMESTANE

DR. KOMAL PARMAR

74 01-May-2019 172650820007 PATEL ARMY PRAKASHBHAI MRW403P 20 265 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



SUBLINGUAL TABLET CONTAINING NISOLDIPINEDR.ANURADHA PRAJAPATI

75 02-May-2019 172120825007 PATEL YASHIKAKUMARI ISHWARBHAI MRW403P 25 212 MP Pharmacology BABE STUDYBIOAVAILABILITY AND BIODISTRIBUTION STUDY OF

RIFAXIMIN CO-CRYSTALS IN RATSDR. RAVI A. MANEK

76 02-May-2019 172130825004 NEMADE MRUNALI ASHOK MRW403P 25 213 MP Pharmacology BABE STUDY

COGNITION ASSESSMENT AMONG INDIAN PATIENTS WITH

HEAD AND NECK CANCER USING PROMIS AND ICCTF

RECOMMENDED TESTS

DR. DEEPTI K. JANI

77 02-May-2019 172130825005 PANDEY RASHI SURESHKUMAR MRW403P 25 213 MP Pharmacology BABE STUDY

BIOEQUIVALENCE STUDY OF FESOTERODINE FUMARATE

PROLONGED RELEASE TABLETS 8 MG IN FASTING

CONDITIONS

DR. DIGVIJAYSINH G. RANA

78 02-May-2019 172130825006 PARMAR MOHINI DHARMENDRASINH MRW403P 25 213 MP Pharmacology BABE STUDYBIOEQUIVALENCE STUDY OF FESOTERODINE FUMARATE

PROLONGED RELEASE TABLETS 8 MG IN FED CONDITIONSDR. DEEPTI K. JANI

79 25-April-2019 172080820002 DHRU KHUSHALI DARSHAKBHAI MRW403P 20 208 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF INTRANASAL DRUG

DELIVERY OF DIAZEPAM FOR STATUS EPILEPTICUS.DR. DASHRATH PATEL

80 25-April-2019 172080820004 RUPARELIYA KETA SHAILESHBHAI MRW403P 20 208 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


NASAL INSITU GEL OF ANTI-HIV DRUG FOR NOSE TO BRAIN

DRUG DELIVERY.DR. SUNITA CHAUDHARY

81 25-April-2019 172280820003 JAHNAVI BHARGAV JANI MRW403P 20 228 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,



TOPICAL PREPARATION OF LUTEIN DR. PRAFUL BHARADIA

82 25-April-2019 172280820004 MANAN VISHNUBHAI PATEL MRW403P 20 228 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND DEVELOPMENT OF ORAL

TRANSMUCOSAL DELIVERY SYSTEM OF AN ANTI-MIGRAINE

AGENT

DR. RADHIKA PANDYA

83 25-April-2019 172280820006 PATEL GRUSHA SANJAYKUMAR MRW403P 20 228 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,



SPIRONOLECTONE GEL FOR TREATMENT OF ANDROGENIC

ALOPECIA

DR. PRAFUL BHARADIA

84 25-April-2019 172420820007 SHAH JIGAR PRADIPKUMAR MRW403P 20 242 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


FLOATING TABLETS OF APREMILASTDR DHAVAL J.PATEL

85 25-April-2019 172620820001 BACHANI KOMAL KANAIYALAL MRW403P 20 262 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF TRANSDERMAL

PATCHES OF ADEFOVIR DIPIVOXIL FOR THE TREATMENT OF

HEPATITIS B

PROF. BHUMI RAVAL

86 26-April-2019 172070820005 Vadaliwala Munavvarbanu Abdullatif MRW403P 20 207 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DEVELOPMENT AND EVALUATION OF ORODISPERSIBLE

TABLET OF APIXABAN

DR. ANANDKUMAR

KANAIYALAL PATEL

87 26-April-2019 172250820008 PATEL VRUNDABEN CHHGANBHAI MRW403P 20 225 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF SUBLINGUAL FILM

OF IVABRADINE HYDROCHLORIDEDR. KEYUR S. PATEL

88 26-April-2019 172470820001 AGRAWAL HIMANSHU GOPALBHAI MRW403P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


PHYSICOCHEMICAL CHARACTERISATION AND IN VITRO

DISSOLUTION ENHANCEMENT OF AGOMELATINE USING

SOLID DISPERSION METHOD

MR. VIJAY K. PATEL

89 26-April-2019 172470820011 PRAJAPATI KAJALBEN ARVINDBHAI MRW403P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF ORALLY

DISINTEGRATING TABLETS OF MIRABEGRONDR. DHARA B. PATEL

90 26-April-2019 172470820013 SHARMA SUNNY SURESHBHAI MRW403P 20 247 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF CONTROLLED

RELEASE OSMOTIC TABLET OF CARVEDILOL PHOSPHATEMR. ANIL G. RAVAL

91 26-April-2019 162250808015 PATEL ROMA BHARATKUMAR 940102 08 225 MP PHARMACEUTICSIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF ORALLY

DISINTEGRATING TABLET OF TRIMEPRAZINEDR. SHAILESH T. PRAJAPATI

92 29-April-2019 172050820008 Tadvi Gaureeben Rajeshbhai MRW403P 20 205 MP Pharmaceutics OTHER (KINDLY SPECIFY)DEVELOPMENT OF DISINTEGRATION CONTROLLED MATRIX

TABLET OF GLIBENCLAMIDEMS. DIPIKA CHAVDA

93 29-April-2019 172130820001 KM SHALINI SHARMA MRW403P 20 213 MP Pharmaceutics OTHER (KINDLY SPECIFY)CYCLODEXTRIN BASED NANOSPONGES: AN EFFECTIVE

METHOD FOR DISSOLUTION ENHANCEMENT OF LOW DR ASHOK MAHAJAN

94 29-April-2019 172130820002 MISTRY JHEEL RAJUBHAI MRW403P 20 213 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF NANOEMULSION

BASED IN-SITU GEL FOR OCULAR DRUG DELIVERY OF

ACECLOFENAC

DR.PRIYAL PATEL

95 29-April-2019 172130820005 PATEL VAISHNAVIBEN PRAVINBHAI MRW403P 20 213 MP Pharmaceutics OTHER (KINDLY SPECIFY)VAGINAL DRUG DELIVERY SYSTEM OF METHOTREXATE FOR

TREATMENT OF RHEUMATOID ARTHRITISDR. NAAZNEEN SURTI

96 29-April-2019 172130820008 TELI ANJALIBEN KUSHALCHANDRA MRW403P 20 213 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT OF TARGETED FORMULATION OF

BUDESONIDE FOR INFLAMMATORY BOWEL DISEASE

MANAGEMENT

DR. MANISHA S. LALAN

97 29-April-2019 172130820009 TRIVEDI RUSHI JAWAHARLAL MRW403P 20 213 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF INTRANASAL IN-SITU

GEL OF PRAMIPEXOLE DIHYDROCHLORIDEDR.MEENAKSHI PATEL

98 29-April-2019 172230828001 DESAI ANJALI DATTATRAY MRW403P 28 223 MPPharmaceutical

TechnologyOTHER (KINDLY SPECIFY)

DEVELOPMENT AND EVALUATION OF SPRAY DRIED

INHALABLE DRY POWDER OF POSACONAZOLE FOR

PULMONARY ASPERGILLOSIS

DR. ALIASGAR J

KUNDAWALA

99 30-April-2019 172120820001 Bhanderi Brijesh Ashokbhai MRW403P 20 212 MP PharmaceuticsNANO SUSPENSION/EMULSION,


DESIGN AND OPTIMIZATION OF LUTEIN LOADED SOLID

LIPID NANOPARTICLES FOR OPTHALMIC DELIVERYDR S R SHAH

100 30-April-2019 172120820004 CHRISTIAN PRAJAL MUKESHBHAI MRW403P 20 212 MP Pharmaceutics MULTIPARTICULATE

FORMULATION AND EVALUATION OF LAFUTIDINE

LIQUISOLID PELLETS FOR ENHANCEMENT OF DISSOLUTION

.

DR J S PAUN

101 30-April-2019 172310820001 Balas Mayur Vashrambhai MRW403P 20 231 MP PharmaceuticsNANO SUSPENSION/EMULSION,


FORMULATION AND EVALUATION OF NIOSOMAL GEL OF

VORICONAZOLE FOR SEVERE FUNGAL INFECTIONDR. SANDIP PATEL

102 30-April-2019 162250808018 YOGENDRAKUMAR TIRATHRAJ MISHRA 940102 08 225 MP PHARMACEUTICSBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF BUCCAL FILM OF

PRAZOCIN HYDROCHLORIDEDR. HEMANGI J. PATEL

103 30-April-2019 162640808007 TANK NITIN RAMESHBHAI 940102 08 264 MP PHARMACEUTICSIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF QUICK DISSOLVING

FILM OF VENLAFAXINE HCI USING NATURAL

POLYSACCHARIDES

MS. DHARMISHTHA A.

MOVALIA

104 01-May-2019 172390820003 CHAUHAN VRUTTIKUMARI BANKIMSINH MRW403P 20 239 MP PharmaceuticsNANO SUSPENSION/EMULSION,


DEVELOPMENT, EVALUATION AND OPTIMIZATION OF

OXICONAZOLE NITRATE LOADED SOLID LIPID

NANOPARTICLE BASED GEL

MR. TULARAM BAROT

105 01-May-2019 172390820006 OZA KIRTIBAHEN MANISHKUMAR MRW403P 20 239 MP PharmaceuticsNANO SUSPENSION/EMULSION,


FORMULATION, EVALUATION AND OPTIMIZATION OF

NANOSUSPENSION FOR DISSOLUTION ENHANCEMENT OF

ZOTEPINE

DR. KOMAL PARMAR

106 01-May-2019 172390820008 PATEL JIGNESHBHAI UTTAMBHAI MRW403P 20 239 MP PharmaceuticsNANO SUSPENSION/EMULSION,


FORMULATION AND DEVELOPMENT OF NOVEL BIGEL

TOPICAL DRUG DELIVERY OF LULICONAZOLEDR. KOMAL PARMAR

107 01-May-2019 172540820001 CHAUHAN RISHABH HEMANTKUMAR MRW403P 20 254 MP PharmaceuticsNANO SUSPENSION/EMULSION,


DEVELOPMENT AND EVALUATION OF GELATIN TREATED

ACECLOFENAC LOADED EUDRAGIT RS 100

NANOSUSPENSION FOR OSTEOARTHRITIS TREATMENT

DR. MANISH GOYANI

108 01-May-2019 172540820003VARADE SNEHALKUMARI

MADHUKARBHAIMRW403P 20 254 MP Pharmaceutics OTHER (KINDLY SPECIFY)

PREPARATION AND CHARACTERIZATION OF SPHERICAL

AGGLOMERATES OF LORATADINE TO IMPROVE

DISSOLUTION RATE AND MICROMERITIC PROPERTIES

DR. BHAVESH AKBARI

109 01-May-2019 172650820003 HALPATI HEMANGINIBEN AMRUTBHAI MRW403P 20 265 MP PharmaceuticsNANO SUSPENSION/EMULSION,


FORMULATION AND EVALUATION OF AZELAIC ACID

EMULGEL FOR ACNE & HYPERPIGMENTATION TREATMENTMRS.ANKITA JAY PATEL

110 02-May-2019 172120825004 MAHETAR NAFISA USMANBHAI MRW403P 25 212 MP PharmacologyRESPIRATORY DISORDER ( PLEASE

SPECIFY DISORDER OR

EVALUATION OF ETHANOLIC EXTRACT OF BOERHAAVIA

DIFFUSA L. LEAVES ON OVALBUMIN INDUCED ASTHMA

MODEL

DR. JIGNESH I. PATEL

111 02-May-2019 172120825008 VAGHASIYA TRUPTI PARSOTAMBHAI MRW403P 25 212 MP PharmacologyRESPIRATORY DISORDER ( PLEASE

SPECIFY DISORDER OR

EVALUATION OF EFFECT OF METHANOLIC EXTRACT OF

TERMINALIA CATAPPA L. IN EXPERIMENTAL ANIMAL

MODEL OF ASTHMA

DR. DEVANG B. SHETH

112 02-May-2019 172390825001 RAJAWAT MAYANK PRAFUL MRW403P 25 239 MP PharmacologyRESPIRATORY DISORDER ( PLEASE

SPECIFY DISORDER OR

PHARMACOLOGICAL SCREENING OF FOUR PROPIETARY

POLYHERBAL FORMULATION FOR THE TREATMENT OF

COUGH.

MR. MITTAL DALAL

113 02-May-2019 172390825004 TANDEL SHIVANI RAJESHBHAI MRW403P 25 239 MP Pharmacology EYE DISORDER

EFFECT OF ISOTINE®, ISOTINE PLUS® AND ISOTINE GOLD®

IN EXPERIMENTAL MODELS OF CATARACT AND

GLAUCOMA.

DR. ARINDAM PAUL

114 02-May-2019 172680825003 PATEL PINESHKUMAR SURESHBHAI MRW403P 25 268 MP PharmacologyRESPIRATORY DISORDER ( PLEASE

SPECIFY DISORDER OR

EVALUATION OF ANTIASTHAMATIC ACTIVITY OF

ETHANOLIC EXTRACT OF LUFFA ECHINATA ROXB. FRUITSMR. VIPUL GAJERA

115 25-April-2019 172060820001 Gokani Preet Nitinkumar MRW403P 20 206 MP Pharmaceutics MISCELANEOUSFORMULATION DEVELOPMENT AND EVALUATION OF

ACECLOFENAC LOADED EMULGELDR. MITTAL MAHESHWARI

116 25-April-2019 172060820003 Swati Adhikari MRW403P 20 206 MP Pharmaceutics MISCELANEOUSIMPACT OF HOLD TIME ON PHYSICAL PARAMETERS OF

DRUG PRODUCTDR. MITTAL MAHESHWARI

117 25-April-2019 172280820002 DESHMUKH GAURI NITEEN MRW403P 20 228 MP Pharmaceutics OTHER (KINDLY SPECIFY)


SOLID ORAL DOSAGE FORM OF PAROXETINE

HYDROCHLORIDE

DR. PRAFUL BHARADIA

118 25-April-2019 172280820008 ROMANSHA ANIL BERI MRW403P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



SUBLINGUAL TABLETS OF AN ANTI-PSYCHOTIC DRUGDR. YAMINI SHAH

119 25-April-2019 172280820010 SOLANKI SNEHABEN BALDEVBHAI MRW403P 20 228 MP Pharmaceutics OTHER (KINDLY SPECIFY)PAEDIATRIC FORMULATION OF CEFIXIME TRIHYDRATE AND

ITS EVALUATIONDR. YAMINI SHAH

120 25-April-2019 172420820001 GOSWAMI ASAV NARENDRAPURI MRW403P 20 242 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


PHYSICOCHEMICAL CHARACTERIZATION AND IN-VITRO

DISSOLUTION ENHANCEMENT OF RANOLAZINE USING

SOLID DISPERSION METHOD

DR S.K.SHAH

121 25-April-2019 162240808010 PATEL PANKIL LALITBHAI 940102 08 224 MP PHARMACEUTICSDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF SUBLINUAL TABLET

OF APREMILASTMR JAYANTI BAJAG

122 26-April-2019 172070820001 MANSURI AKIBBHAI YASINBHAI MRW403P 20 207 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT AND CHARACTERIZATION OF CONTROLLED

RELEASE MATRIX TABLET OF TIAGABINE HYDROCHLORIDE

DR. ANANDKUMAR

KANAIYALAL PATEL

123 26-April-2019 172250820002 KANSAGARA AMEEBEN RAMNIKBHAI MRW403P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF COLON TARGETED

TABLETS OF ELUXADOLINEDR. SHAILESH T. PRAJAPATI

124 26-April-2019 172250820004 PATEL JASMINABAHEN VISHNUBHAI MRW403P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


MATRIX TABLETS OF NATEGLINIDEDR. SHAILESH T. PRAJAPATI

125 26-April-2019 172250820005 PATEL NILESHKUMAR MUKESHBHAI MRW403P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF GASTRORETENTIVE

MUCOADHESIVE TABLETS OF RANOLAZINEDR. KEYUR S. PATEL

126 26-April-2019 172250820007 PATEL SUMIT RAJESHBHAI MRW403P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF FLOATING TABLETS

OF PROPAFENONE HYDROCHLORIDEDR. KEYUR S. PATEL

127 26-April-2019 172450820002 Vaghela Harshkumar Chamanlal MRW403P 20 245 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

PREPARATION AND EVALUATION OF SUSTAINED RELEASE

TABLET OF NIFEDIPINEDR. P. H. PRAJAPATI

128 26-April-2019 172520820001 BULA SANA MOHAMMADHUSAIN MRW403P 20 252 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT AND CHARACTERIZATION OF FLOATING-

MUCOADHESIVE TABLET CONTAINING QUETIAPINE

FUMARATE

DR ALPESH D PATEL

129 29-April-2019 172050820003 Panchal Punam Ketankumar MRW403P 20 205 MP Pharmaceutics MISCELANEOUSDEVELOPMENT AND EVALUATION OF GLIPIZIDE PASTILLES

BY EMPLOYING QUALITY BY DESIGN APPROACHMR. HARDIK RANA

130 29-April-2019 172050820004 Patel Ashviniben Dilipbhai MRW403P 20 205 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DEVELOPMENT AND OPTIMIZATION OF ORAL SPRAY OF

TADALAFIL EMPLOYING QbD APPROACHMR. HARDIK RANA

131 29-April-2019 172050820006 Raut Jignasaben Devrambhai MRW403P 20 205 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DISSOLUTION ENHANCEMENT OF BOSWELLIA SERRATA

EXTRACT BY LIQUISOLID APPROACH MS. DIPIKA CHAVADA

132 29-April-2019 172050820007 Tadvi Arunaben Kanchanbhai MRW403P 20 205 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DISSOLUTION ENHANCEMENT OF BICALUTAMIDE BY

DEVELOPING SOLID DISPERSION EMPLOYING MICROWAVE DR. VAISHALI T. THAKKAR

133 29-April-2019 172130820003 NAZIYA ILYAS GHEEWALA MRW403P 20 213 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


SPRAY DRIED SOLID DISPERSION : AN EFFICIENT METHOD

FOR DISSOLUTION ENHANCEMENT OF NEVIRAPINEDR ASHOK MAHAJAN

134 29-April-2019 172130820006 PATEL VRUNDA SANJAYKUMAR MRW403P 20 213 MP Pharmaceutics MISCELANEOUSPREPARATION AND EVALUATION OF DRY POWDER

INHALER FORMULATION FOR PULMONARY DELIVERY OF DR.PRIYAL PATEL

135 29-April-2019 172440820003 PATEL RIKIN RAMESH MRW403P 20 244 MP Pharmaceutics OTHER (KINDLY SPECIFY)FORMULATION, DEVELOPMENT AND EVALUATION OF

MEDICATED CHEWING GUM OF AVANAFILM. RAHIL G. BHURA

136 30-April-2019 172120820008 MAVANI CHINTAN PRAVINBHAI MRW403P 20 212 MP Pharmaceutics

CO PROCESSED, DC,


AT

DEVELOPMENT AND CHARACTERIZATION OF NOVEL CO-

PROCESSED EXCIPIENT OF TRICALCIUM CITRATE BY SPRAY

DRYING.

DR R D PARMAR

137 30-April-2019 172120820011 PRAJAPATI RAVIRAJ RAMESHKUMAR MRW403P 20 212 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DESIGN AND EVALUATION OF TRANSDERMAL PATCH

CONTAINING GRANISETRON HYDROCHLORIDEDR. J M PATEL

138 30-April-2019 172120820012 PRAJAPATI URVASHI RAMESHBHAI MRW403P 20 212 MP PharmaceuticsCO PROCESSED, DC,


PHYSICOCHEMICAL PROPERTY IMPROVEMENT OF

CEFPODOXIME PROXETIL BY CO PROCESSINGDR. JAYANT R. CHAVDA

139 30-April-2019 172120820013 SAKHIYA DHRUV CHANDRAKANTBHAI MRW403P 20 212 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


PREPARATION AND EVALUTION OF ITRACONAZOLE

TOPICAL NANOGELDR C H BORKHATARIYA

140 30-April-2019 172120820014 SANGHANI DIVYABEN VINODBHAI MRW403P 20 212 MP Pharmaceutics

CO PROCESSED, DC,


AT

AUGMENTATION OF PHYSICOCHEMICAL PROPERTIES OF

CEFUROXIME AXETIL BY SPHERICAL AGGLOMERATION.DR R D PARMAR

141 30-April-2019 172310820002 Garachar Dhaval Ranabhai MRW403P 20 231 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND CHARACTERIZATION OF ACARBOSE

OSMOTIC TABLETSMR. SUMIT CHAKRABORTY

142 30-April-2019 172310820003 KALARIA VISHWA JITENDRABHAI MRW403P 20 231 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DESIGN AND EVALUATION OF INSITU GEL EYE DROPS

CONTAINING NANOPARTICLES OF GEMIFLOXACIN

MESYLATE

MR. SUMIT CHAKRABORTY

143 01-May-2019 172150824002 GUPTA VANDANA BARJENDRA MRW403P 24 215 MPPharmaceutical

Quality AssuranceSIMULTENEOUS ESTIMATION

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION

FOR FLUPIRTINE MALEATE AND TRAMADOL

HYDROCHLORIDE IN SYNTHETIC MIXTURE

DR. ZARNA DEDANIA

144 01-May-2019 172150824003 KERIWALA TEJAL MANOJKUMAR MRW403P 24 215 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF UV SPECTROSCOPIC

AND HPLC METHODS FOR LULICONAZOLE AND

BECLOMETHASONE DIPROPIONATE IN COMBINED

PHARMACEUTICAL DOSAGE FORM.

DR. GHANSHYAM

SHANGHANI

145 01-May-2019 172150824005 SHAH ABHISHEKKUMAR BHARATKUMAR MRW403P 24 215 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF UV SPECTROSCOPIC

AND HPLC METHODS FOR ZONISAMIDE AND CILOSTAZOL

IN SYNTHETIC MIXTURE.

DR. ZARNA DEDANIA

146 01-May-2019 172390824001 BHANUSHALI PRIYA DEVJIBHAI MRW403P 24 239 MPPharmaceutical


SPECTROSCOPIC AND CHROMATOGRAPHIC METHODS

DEVELOPMENT FOR SIMULTANEOUS ESTIMATION OF

CILNIDIPINE AND BISOPROLOL FUMARATE IN COMBINED

DOSAGE FORM

DR. ALISHA PATEL

147 01-May-2019 172390824002 KAMLI ANKITA SHANTILAL MRW403P 24 239 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF ANALYTICAL

METHODS FOR SIMULTANEOUS ESTIMATION OF

CANDESARTAN CILEXETIL AND AMLODIPINE BESYLATE IN

SYNTHETIC MIXTURE

MADHURI HINGE

148 01-May-2019 172390824003 KUMBHAR RIDDHI SHIVAJI MRW403P 24 239 MPPharmaceutical


ANALYTICAL METHODS DEVELOPMENT AND VALIDATION

FOR AMLODIPINE BESYLATE AND CELECOXIB AND DR. ALISHA PATEL

149 02-May-2019 172120825005 MATHUR ANMOL CHETENDRAKUMAR MRW403P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY)

EVALUATION OF ANTI-ARTHRITIC POTENTIAL OF

METHANOLIC EXTRACT OF WHOLE PLANT OF BIOPHYTUM

SENSITIVUMIN FREUNDS ADJUVANT INDUCED ARTHRITIS

DR. JIGNESH I. PATEL

150 02-May-2019 172120825009 VAGHELA UJJVAL PARESHBHAI MRW403P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY)EFFECT OF ETHANOLIC EXTRACT OF PUERARIA TUBEROSA

(WILLD.)DC. TUBERS IN LETROZOLE INDUCED POLYCYSTIC DR. DEVANG B. SHETH

151 02-May-2019 172130825002 MAYUR WANKHADE MRW403P 25 213 MP Pharmacology OTHER (KINDLY SPECIFY)NUTRACEUTICAL INTERVENTIONS IN PACLITAXEL-

INDUCED NEUROPATHIC PAIN: AN EXPERIMENTAL STUDYDR. DEEPTI K. JANI

152 02-May-2019 172390825003 SHAIKH UMAIRA ABDULRAKIB MRW403P 25 239 MP Pharmacology OTHER (KINDLY SPECIFY)ANTICOAGULANT AND ANTIHEMOLYTIC ACTIVITY OF

TECOMELLA UNDULATA -AN EXPERIMENTAL STUDYDR. ANKIT H MERAI

153 02-May-2019 172680825002 PARMAR POOJA SURESHCHANDRA MRW403P 25 268 MP Pharmacology OTHER (KINDLY SPECIFY)

EVALUATION OF ANTI-ARTHRITIC ACTIVITY OF BLUMEA

BALSAMIFERA (L.) DC. IN EXPERIMENTALLY INDUCED

ARTHRITIS IN RATS.

MR. VIPUL GAJERA

154 25-April-2019 172060824001 CHAUHAN SUDIKSHA RAMKUMAR MRW403P 24 206 MPPharmaceutical

Quality AssuranceSTABILITY STUDIES

STABILITY INDICATING RP-UPLC METHOD DEVELOPEMENT

AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF

ASPIRIN, ROSUVASTATIN CALCIUM AND CLOPIDOGREL

BISULPHATE IN TABLET

DR. NEHA TIWARI

155 25-April-2019 172060824006 PATEL DIPALIBEN JAYANTIBHAI MRW403P 24 206 MPPharmaceutical


STABILITY INDICATING RP-UPLC METHOD DEVELOPEMENT

AND VALIDATION FOR OLMESARTAN MEDOXOMIL, DR. NEHA TIWARI

156 25-April-2019 172080824001 PANCHAL URVISHA GOVINDBHAI MRW403P 24 208 MPPharmaceutical


STABILITY INDICATING HPTLC METHOD DEVELOPMENT

AND VALIDATION OF DACLATASVIR DIHYDROCHLORIDE IN

PHARMACEUTICAL DOSAGE FORM

DR. RAGIN SHAH

157 25-April-2019 172080824004 PATEL NIDHIBEN VINODBHAI MRW403P 24 208 MPPharmaceutical


STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT

AND VALIDATION OF DOFETILIDE IN CAPSULE DOSAGE

FORM

DR NISHA PARIKH

158 25-April-2019 172080824006 SHAH CHARMI RAJESH MRW403P 24 208 MPPharmaceutical



AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION MS JIGNASHA DERASARI

159 25-April-2019 172240824001 CHAUDHARY RAJESHBHAI BHIKHABHAI MRW403P 24 224 MPPharmaceutical


STABILITY INDICATING HPLC METHOD DEVELOPMENT AND

VALIDATION FOR SIMULTANEOUS ESTIMATION OF

SERTACONAZOLE NITRATE AND BECLOMETHASONE

DR. HIRAL PANCHAL

160 25-April-2019 172240824002 DAMSIYA NIKHIL KARSHANBHAI MRW403P 24 224 MPPharmaceutical



VALIDATION FOR SIMULTANEOUS ESTIMATION OF DR. HIRAL PANCHAL

161 26-April-2019 172250824002 HIRAPARA FENIBEN JAYANTILAL MRW403P 24 225 MPPharmaceutical



VALIDATION OF AMOXYCILLIN AND CLAVULANIC ACID IN

TABLET

Dr. SAMIR C. PATEL

162 26-April-2019 172450824001 PATEL RITUBEN JASHVANTBHAI MRW403P 24 245 MPPharmaceutical


STABILITY STUDY OF SULTAMICILLIN AND ITS TABLET

FORMULATION UNDER ACCELERATED AND STRESS DR. J. B. DAVE

163 26-April-2019 172470824001 ANSARI AFSHANNIKHAT AQEELAHMED MRW403P 24 247 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF STABILITY

INDICATING RP-HPLC METHOD FOR ESTIMATION OF

SERTACONAZOLE NITRATE AND BECLOMETHASONE

MS. ANKITA S. PATEL

164 26-April-2019 172470824002 DHARU NEETUKUMARI RAJESHBHAI MRW403P 24 247 MPPharmaceutical



INDICATING RP-HPLC METHOD FOR SIMULTANEOUS

ESTIMATION OF NADIFLOXACIN AND CLOBETASOL

MS. KUNJAL L. VEGAD

165 26-April-2019 172470824003 HARDIK KIRTIKUMAR BHAVSAR MRW403P 24 247 MPPharmaceutical



INDICATING ASSAY METHOD FOR ESTIMATION OF DR. VINAY C. DARJI

166 26-April-2019 172470824008 PATEL RINKAL MUKESHBHAI MRW403P 24 247 MPPharmaceutical




OXYCODONE HCL AND NALTREXONE HCL IN CAPSULE

MR. KAUSHIK R. PATEL

167 26-April-2019 172470824011 PATIL POOJA SATISHBHAI MRW403P 24 247 MPPharmaceutical




MICONAZOLE NITRATE AND HYDROCORTISONE IN CREAM

DR. VINAY C. DARJI

168 26-April-2019 172470824012 Rathod Jinal Harshadkumar MRW403P 24 247 MPPharmaceutical




ESTIMATION OF CLOTRIMAZOLE, CLINDAMYCIN

MR. JAYMIN G. PATEL

169 29-April-2019 172020824001 PATEL TWINCYBEN KIRITBHAI MRW403P 24 202 MPPharmaceutical

Quality AssuranceOTHER (KINDLY SPECIFY)


INDICATING HPTLC METHOD FOR PERAMPANEL IN IT’S

TABLET DOSAGE FORM

DR. RAJENDRA MEHTA

170 29-April-2019 172050824004 PATEL KRISHNA SURESHBHAI MRW403P 24 205 MPPharmaceutical


FORMULATION DEVELOPMENT AND SIMULTANEOUS

ESTIMATION OF TADALAFIL AND DAPOXETINE

HYDROCHLORIDE IN NEWER COMBINED DOSAGE FORM

USING QBD APPROACH

DR. PURVI A. SHAH

171 29-April-2019 172050824006 Shah Nejal Nitinkumar MRW403P 24 205 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD

FOR QUANTIFICATION OF NEPAFENAC IN NEWER

OPTIMIZED OPHTHALMIC FORMULATION

DR. KALPANA G. PATEL

172 29-April-2019 172130824008 UPADHYAY KHYATIBEN VIJAYKUMAR MRW403P 24 213 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF LIQUID

CHROMATOGRAPHIC METHOD FOR ESTIMATION OF DR. DIMAL SHAH

173 29-April-2019 172230823002 Patel Keshaben Manojbhai MRW403P 23 223 MPPharmaceutical

AnalysisOTHER (KINDLY SPECIFY)


METHODS FOR THE QUANTIFICATION OF MACITENTAN IN

BULK AND PHARMACEUTICAL DOSAGE FORM

DR. USMANGANI K.

CHHALOTIYA

174 29-April-2019 172230823003 YADAV PREETIBEN NARESHKUMAR MRW403P 23 223 MPPharmaceutical

AnalysisOTHER (KINDLY SPECIFY)

DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC

AND UV-VISIBLE SPECTROSCOPIC METHODS FOR

QUANTIFICATION OF MIRABEGRON IN BULK AND


DR. USMANGANI K.

CHHALOTIYA

175 29-April-2019 172460824004 PRACHI GUPTA MRW403P 24 246 MPPharmaceutical

Quality AssuranceQUALITY RISK MANAGEMENT

A SYSTEMATIC APPROACH TO NEW PRODUCT

INTRODUCTION WITH EMPHASIS ON THE

CONTAINMENT STRATEGIES AND QUALITY RISK

DR ANKITA BHAVSAR

176 30-April-2019 172120824001 Chavda Meghaben MRW403P 24 212 MPPharmaceutical

Quality AssuranceIMPURITY PROFILING


FOR ESTIMATION OF GENOTOXIC IMPURITIES IN

RANOLAZINE API BY GAS CHROMATOGRAPHY

DR. ASHOK B. PATEL

177 30-April-2019 172120824003 DHADUK AKTABEN RAMESHBHAI MRW403P 24 212 MPPharmaceutical


QUALITY BY DESIGN APPROACH TO FIND DESIGN SPACE IN

THE DEVELOPMENT OF RP-HPLC METHOD FOR

ESTIMATION OF AMITRIPTYLINE HYDROCHLORIDE BY

MR. AJAY I. PATEL

178 30-April-2019 172630824001 PATEL SAPANA JOITARAM MRW403P 24 263 MPPharmaceutical


RP-HPLC METHOD FOR DETERMINATION OF ADAPALENE

USING CENTRAL COMPOSITE DESIGN DR. PARULA PATEL

179 30-April-2019 172820824001 PATEL BIRAJKUMAR VIJAYBHAI MRW403P 24 282 MPPharmaceutical



INDICATING RP-HPLC METHOD FOR FLUCONAZOLE AND

BECLOMETHASONE IN ITS COMBINED DOSAGE FORM

DR. M.B. SHANKAR

180 30-April-2019 172820824002 PATEL SUNNY HEMANTKUMAR MRW403P 24 282 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF LIQUID

CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS DR. M.B.SHANKAR

181 01-May-2019 172150824004 PRAJAPATI RICHA ATULBHAI MRW403P 24 215 MPPharmaceutical


QBD APPROACH TO HPLC METHOD DEVELOPMENT AND

VALIDATION FOR THE ESTIMATION OF FLUOXETINE

HYDROCHLORIDE AND OLANZAPINE IN PHARMACEUTICAL

DR. ZARNA DEDANIA

182 01-May-2019 172540824001 ANCY MATHEW MRW403P 24 254 MPPharmaceutical



FOR THE ESTIMATION OF VORTIOXETINE AND

ARIPIPRAZOLE IN SYNTHETIC MIXTURE

DR. SURESH KUMAR

183 01-May-2019 172540824002 Jangra Sandeepkumar Parasram MRW403P 24 254 MPPharmaceutical



METHODS FOR THE ESTIMATION OF MIRABEGRON AND

SOLIFENACIN SUCCINATE IN SYNTHETIC MIXTURE

DR. SURESH KUMAR

184 01-May-2019 172540824003 MAHIDA KAJAL RAKESHKUMAR MRW403P 24 254 MPPharmaceutical



METHODS FOR THE ESTIMATION OF DOXOFYLLINE AND DR. SURESH KUMAR

185 01-May-2019 172540824005 PATEL HINAL HARISHBHAI MRW403P 24 254 MPPharmaceutical


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF

SIMULTANEOUS ESTIMATION OF PREGABALIN AND

MELOXICAM IN BINARY MIXTURE

MR. ROHAN BARSE

186 01-May-2019 172540824006 VARACHHIYA HIRAL JASVANTSINH MRW403P 24 254 MPPharmaceutical



METHODS FOR THE ESTIMATION OF ITOPRIDE MR. ROHAN BARSE

187 02-May-2019 172050825001 Himanshi Ravinder Kaul MRW403P 25 205 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EVALUATION OF ANTI-OBESITY ACTIVITY OF CORIANDRUM

SATIVUM IN RAT MODELDR. TEJAL R. GANDHI

188 02-May-2019 172050825003 NAIR KARISHMA JAYPRAKASH MRW403P 25 205 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EVALUATION OF NOX-4 INHIBITOR -QUERCETIN IN 10

WEEKS RAT MODEL OF DIABETIC NEPHROPATHYDR. TEJAL R. GANDHI

189 02-May-2019 172280825002 DOBARIYA KOMAL MRW403P 25 228 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EVALUATE THE THERAPEUTIC POTENTIAL OF CHRYSIN IN

TYPE -2 DIABETES AND ITS COMPLICATIONSDR. ANITA A MEHTA

190 02-May-2019 172280825003 GORAKHIYA MONIKA SHAILESHBHAI MRW403P 25 228 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

ASSESSMENT OF INSULIN EFFECT IN HYPOTHYROIDISM

AND OBESITY IN RATS

DR. MUSTAKIM M.

MANSURI

191 02-May-2019 172280825004 JAINEEL RAJESHBHAI DHAROD MRW403P 25 228 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EVALUATION OF ANTI-OBESITY EFFECT OF BUPROPION

AND L-HISTIDINE COMBINATION IN HFD INDUCED OBESITY

IN MICE

DR. GAURANG B. SHAH

192 02-May-2019 172280825009 YADAV RUCHIBEN SHITALAPRASAD MRW403P 25 228 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EFFECT OF GENISTEIN ON OVARIAN FUNCTION IN

HYPOTHYRODISED RAT

DR. MUSTAKIM M.

MANSURI

193 02-May-2019 172680825001 MISTRY SHIVANGIBEN NARESHKUMAR MRW403P 25 268 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EVALUATION OF ANTIDIABETIC POTENTIAL OF LUFFA

ECHINATA ROXB. IN WISTAR RATSDR. VIJAY LAMBOLE

194 25-April-2019 172060824002 Dodiya Karan sinh Vajesangbhai MRW403P 24 206 MPPharmaceutical




ESTIMATION OF DIAZEPAM AND DICYCLOMINE IN THEIR

DR. PRAGNESH PATANI

195 25-April-2019 172060824003 GUPTA MONIKA HARERAM MRW403P 24 206 MPPharmaceutical


DEVELOPEMENT AND VALIDATION OF STABILITY


ESTIMATION OF DOXOFYLLINE AND ACEBROPHYLLINE IN

DR.PRAGNESH PATANI

196 25-April-2019 172060824004 MUDALIAR REVATI GANESHBHAI MRW403P 24 206 MPPharmaceutical



INDICATING ASSAY RP-HPLC METHOD FOR THE

SIMULTANEOUS ESTIMATION OF DICYCLOMINE AND

DR. PRAGNESH PATANI

197 25-April-2019 172060824012 VAGHELA YAVANTIKA VIRENDRASINH MRW403P 24 206 MPPharmaceutical



INDICATING RP-HPLC METHOD FOR THE ESTIMATION OF

DAPAGLIFLOZIN IN ITS TABLET DOSAGE FORM

DR. PRAGNESH PATANI

198 25-April-2019 172420824003 MANGROLIYA RUCHITA HIMMATBHAI MRW403P 24 242 MPPharmaceutical

Quality AssurancePROCESS VALIDATION

PROSPECTIVE PROCESS VALIDATION OF

ANTIINFLAMMATORY (CORTICOSTEROID) INJECTION

SUSPENSION USP 40 MG/ML

DR. ANKIT B. CHAUDHARY

199 25-April-2019 172420824005 SUDHIRKUMAR GAMI MRW403P 24 242 MPPharmaceutical


RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR

SIMULTANEOUS ESTIMATION OF BENIDIPINE

HYDROCHLORIDE, TELMISARTAN AND CHLORTHALIDONE


200 26-April-2019 172250824004 KACHCHHI RIDDHI RAMESHBHAI MRW403P 24 225 MPPharmaceutical


STABILITY INDICATING CHROMATOGRAPHIC METHOD

DEVELOPMENT AND VALIDATION OF SERTACONAZOLE

NITRATE AND ZINC PYRITHIONE IN SHAMPOO

DR. DEEPA R. PATEL

201 26-April-2019 172250824006 PATEL LAVINA GHANSHYAMBHAI MRW403P 24 225 MPPharmaceutical



DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS

ESTIMATION OF FLUCONAZOLE AND BECLOMETHASONE

DIPROPIONATE IN CREAM

DR. DEEPA R. PATEL

202 26-April-2019 172470824004 MEGHA JINAL MUKESHBHAI MRW403P 24 247 MPPharmaceutical



STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION

OF BENIDIPINE HCL, TELMISARTAN AND CHLORTHALIDONE

IN TABLET

MS. ANKITA S. PATEL

203 26-April-2019 172470824006 PATEL DHARABEN BHARATKUMAR MRW403P 24 247 MPPharmaceutical




OF PARACETAMOL AND ZALTOPROFEN IN TABLET

MR. KAUSHIK R. PATEL

204 26-April-2019 172470824007 PATEL POOJABEN AJAYBHAI MRW403P 24 247 MPPharmaceutical




OF BRINZOLAMIDE AND BRIMONIDINE TARTRATE IN

DR. VINAY C. DARJI

205 26-April-2019 172470824009 PATEL SEEMA NITINBHAI MRW403P 24 247 MPPharmaceutical



STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION MS. BHUMI R. PATEL

206 26-April-2019 172470824010 PATEL UPASANA KANTILAL MRW403P 24 247 MPPharmaceutical




OF MEROPENEM AND VABORBACTAM IN SYNTHETIC

MIXTURE

MR. JAYMIN G. PATEL

207 26-April-2019 172470824015 VYAS KAJAL SHAILESHKUMAR MRW403P 24 247 MPPharmaceutical



INDICATING RP-HPLC METHOD FOR SIMULTANEOUS MS. ANKITA S. PATEL

208 29-April-2019 172020824002 THESIYA KRISHNABEN BHARATKUMAR MRW403P 24 202 MPPharmaceutical



INDICATING HPTLC METHOD FOR RIOCIGUAT IN TABLET

DOSAGE FORM

DR.(MRS) ANANDKUMARI

D CAPTAIN

209 29-April-2019 172130824001 JOSHI KRUPABEN PRAVINBHAI MRW403P 24 213 MPPharmaceutical



FOR THE ESTIMATION OF FLIBANSERIN IN THE PRESENCE

OF ITS RELATED SUBSTANCE

DR. FALGUN A. MEHTA

210 29-April-2019 172130824003 NAIR SHREYA RADHAKRISHNAN MRW403P 24 213 MPPharmaceutical



FOR THE ESTIMATION OF POLMACOXIB IN PRESENCE OF DR. FALGUN A. MEHTA

211 29-April-2019 172130824004 PANCHAL PRACHI VISHNUKUMAR MRW403P 24 213 MPPharmaceutical



FOR THE ESTIMATION OF NETUPITANT IN THE PRESENCE

OF ITS RELATED SUBSTANCE

DR. FARHATJAHAN SHAIKH

212 29-April-2019 172460824002 DESAI PAMIL SHAMJIBHAI MRW403P 24 246 MPPharmaceutical



INDICATING METHOD FOR ESTIMATION OF RIOCIGUAT

IN BULK AND PHARMACEUTICAL DOSAGE FORM

DR ANKITA BHAVSAR

213 30-April-2019 172120824002CHOUDHARY JYOTISHNA

BHOOPALSINGHMRW403P 24 212 MP

Pharmaceutical



FOR THE ESTIMATION OF ARTEMETHER AND

LUMEFANTRINE IN MARKETED FORMULATION BY UPLC

DR. ASHOK B. PATEL

214 30-April-2019 172120824010 MODH JAIVIK HITESHKUMAR MRW403P 24 212 MPPharmaceutical



FOR ESTIMATION OF DICLOFENAC DIETHYLAMINE TOPICAL

SOLUTION BY RP-HPLC METHOD

DR. NILESH K. PATEL

215 30-April-2019 172120824012 PATEL KRUPALIBEN JAGADISHBHAI MRW403P 24 212 MPPharmaceutical


SIMULTANEOUS ESTIMATION OF DAPAGLIFLOZIN

PROPANEDIOL MONOHYDRATE & METFORMIN HCL IN DR.AMITKUMAR J .VYAS

216 30-April-2019 172120824013 PATEL RUPALBEN ASHOKBHAI MRW403P 24 212 MPPharmaceutical



INDICATING ASSAY METHOD FOR SIMULTANEOUS DR. ASHOK B. PATEL

217 01-May-2019 172390824005 PATEL HETA AMRUTBHAI MRW403P 24 239 MPPharmaceutical




MRS. MEGHA ASHESH

SHAH

218 01-May-2019 172650824001 BHADRA RINKALBEN MAHESHBHAI MRW403P 24 265 MPPharmaceutical

Quality AssuranceBIOANALYTICAL

BIOANALYTICAL METHOD DEVELOPMENT AND

VALIDATION FOR ESTIMATION OF PRIMIDONE IN K3EDTA DR.SHAILESH LUHAR

219 01-May-2019 172650824003 KHETIYA MEGHA MANOJBHAI MRW403P 24 265 MPPharmaceutical



VALIDATION FOR ESTIMATION OF PAROXETINE

DR. SACHIN BHASKAR

NARKHEDE

220 01-May-2019 172650824006 PRAJAPATI HIRAL ARVINDBHAI MRW403P 24 265 MPPharmaceutical



VALIDATION FOR ESTIMATION OF ATAZANAVIR IN K3EDTA DR. CHIRAG DESAI

221 01-May-2019 172650824007 RATHOD SHEETAL JAGDISHCHANDRA MRW403P 24 265 MPPharmaceutical



VALIDATION FOR ESTIMATION OF NINTEDANIB IN K3EDTA

HUMAN PLASMA BY USING LC-APCI-MS/MS

DR.SHAILESH LUHAR

222 01-May-2019 172680824001 PARMAR VIRANCHI JITENDRASINH MRW403P 24 268 MPPharmaceutical




VORTIOXETINE HYDROBROMIDE IN PHARMACEUTICAL

DOSAGE FORM.

MR. SAGARKUMAR P.

PATEL

223 02-May-2019 172130825001 KUNDU SMITA SUMANKUMAR MRW403P 25 213 MP Pharmacology CNS DISORDEREVALUATION OF ACTIVITY OF LOXOPROFEN IN VARIOUS

ANIMAL MODELS OF DEPRESSIONDR. DIGVIJAYSINH G. RANA

224 02-May-2019 172130825003 Mitra Pratik Sapan MRW403P 25 213 MP Pharmacology CNS DISORDEREVALUATION OF ACTIVITY OF TERIFLUNOMIDE IN VARIOUS


225 02-May-2019 172130825007 PATEL RUTU MANOJKUMAR MRW403P 25 213 MP Pharmacology CNS DISORDEREVALUATION OF ACTIVITY OF MONTELUKAST IN VARIOUS


226 02-May-2019 172540825001 CHAUHAN VATSALSINH RAJENDRASINH MRW403P 25 254 MP Pharmacology CNS DISORDER

pharmacological evaluation of Operculina turpethum root

extract in scopolamine-induced cognitive impairments in

rats.

DR. PALLAVI K.J

227 02-May-2019 172540825003 PARMAR JANHAVI ANILKUMAR MRW403P 25 254 MP Pharmacology CNS DISORDER

pharmacological evaluation of Anti-inflammatory & Anti-

nociceptive activities of Doronicum hookeri root extract in

rats

DR. PALLAVI K.J

228 02-May-2019 172540825004 SHAIKH ZEBABIBI ZAHIR MRW403P 25 254 MP Pharmacology CNS DISORDERpharmacological evaluation of Antidepressant activity of

Vigna radiata seed extract in rats.DR. PALLAVI K.J

229 25-April-2019 172280824004 MODI PINAL SATISHKUMAR MRW403P 24 228 MPPharmaceutical




NEBIVOLOL HYDROCHLORIDE AND TELMISARTAN IN THEIR

COMBINED DOSAGE FORM

DR. SINDHU EZHAVA

230 25-April-2019 172420824006 SUTHAR NISHABEN JAYESHKUMAR MRW403P 24 242 MPPharmaceutical




ORLISTAT AND RESVERATROL IN CAPSULE

MS. CHARMY D. PANDYA

231 25-April-2019 172620824001 BASITA NIKHIL CHAMPAKBHAI MRW403P 24 262 MPPharmaceutical



FOR SIMULTANEOUS ESTIMATION OF PIOGLITAZONE

HYDROCHLORIDE AND VILDAGLIPTIN IN SYNTHETIC

MIXTURE

DR. JITENDRA O.

BHANGALE

232 25-April-2019 172620824002 DAVE MANSIBEN SHIRISHKUMAR MRW403P 24 262 MPPharmaceutical



FOR SIMULTANEOUS ESTIMATION OF LOSARTAN

POTASSIUM AND ROSUVASTATIN CALCIUM IN SYNTHETIC

MIXTURE

DR. JITENDRA O.

BHANGALE

233 25-April-2019 172620824009 PATEL HIRAL ASHOKBHAI MRW403P 24 262 MPPharmaceutical



FOR SIMULTANEOUS ESTIMATION OF RAMIPRIL AND

SIMVASTATIN IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

234 25-April-2019 172620824011 SONARA KAJAL HARIBHAI MRW403P 24 262 MPPharmaceutical



FOR SIMULTANEOUS ESTIMATION OF REPAGLINIDE AND

SITAGLIPTIN PHOSPHATE IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

235 26-April-2019 172250824007 PATEL PINKI RANCHHODBHAI MRW403P 24 225 MPPharmaceutical



DEVELOPMENT AND VALIDATION OF ENROFLOXACIN AND

BROMHEXINE HCI IN COMBINED DOSAGE FORM

DR. DEEPA R. PATEL

236 26-April-2019 172250824008 SK MOTIUR RAHAMAN MRW403P 24 225 MPPharmaceutical



DEVELOPMENT AND VALIDATION OF BETAHISTINE

DIHYDROCHLORIDE AND DOMPERIDONE IN COMBINED

DOSAGE FORM

Dr. SAMIR C. PATEL

237 26-April-2019 172250824009 VYAS RAMA SHIVKUMAR MRW403P 24 225 MPPharmaceutical


STABILITY INDICATING HPLC METHOD FOR

STIMULTANEOUS ESTIMATION OF SERTACONAZOLE AND

BECLOMETHASONE IN THEIR COMBINED DOSAGE FORM

DR. DEEPA R. PATEL

238 26-April-2019 172780824004 PATEL HARSHITKUMAR PANKAJBHAI MRW403P 24 278 MPPharmaceutical



FOR THE SIMULTANEOUS ESTIMATION OF FLUCONAZOLE

AND BECLOMETHASONE DIPROPIONATE IN COMBINED


DR RAJESH K PATEL

239 26-April-2019 172780824005 PATEL HINAL BALDEVBHAI MRW403P 24 278 MPPharmaceutical



METHODS FOR THE SIMULTANEOUS ESTIMATION OF

DEXCHLOPHENIRAMINE MELEATE AND BETAMETHASONE

DR MITALI SHRIMANKER

240 29-April-2019 172050824002 Chunara Kiranben Rameshchandra MRW403P 24 205 MPPharmaceutical




EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE IN

NEWER PHARMACEUTICAL FORMULATION

DR. PURVI A. SHAH

241 29-April-2019 172050824003 DESAI JINAL HEMANTKUMAR MRW403P 24 205 MPPharmaceutical

Quality AssuranceHERBAL


FOR ESTIMATION OF BERBERINE AND RETINOIC ACID IN

NOVEL HERBAL FORMULATION USING EXPERIMENTAL

DESIGN

DR.KALPANA G. PATEL

242 29-April-2019 172050824007 Shah Nischay Sunil MRW403P 24 205 MPPharmaceutical


FORMULATION DEVELOPMENT AND ANALYTICAL METHOD

DEVELOPMENT FOR FLUCONAZOLE AND QUERCETIN IN

NOVEL TOPICAL GEL FORMULATION

MR. HITESH G. RAVAL

243 29-April-2019 172130824002MIRZA NILAMFATEMA

MOHAMMADASKARIMRW403P 24 213 MP

Pharmaceutical




PITAVASTATIN CALCIUM AND EZETIMIBE FROM ITS

DR. VANDANA B. PATEL

244 29-April-2019 172130824005 PARMAR PAYAL MAHESHBHAI MRW403P 24 213 MPPharmaceutical



METHODS FOR ESTIMATION OF VALBENAZINE TOSYLATE IN

BULK

DR. VANDANA B. PATEL

245 29-April-2019 172130824006 PRAJAPATI DHRUVI ANILKUMAR MRW403P 24 213 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD

FOR ANALYSIS OF ALOGLIPTIN BENZOATE IN THE PRESENCE

OF ITS RELATED SUBSTANCES

DR. SHAILESH KORADIA

246 29-April-2019 172130824007 TAHILRAMANI POOJA JAGDISH MRW403P 24 213 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF UV AND

CHROMATOGRAPHIC METHODS FOR ESTIMATION OF

MIRABEGRON AND SOLIFENACIN SUCCINATE IN

COMBINATION

DR. DIMAL SHAH

247 30-April-2019 172120824005 JANI SHIVANI NILESHKUMAR MRW403P 24 212 MPPharmaceutical

Quality AssuranceREGULATORY AFFAIRS

STUDY OF REGULATORY REQUIREMENTS FOR

PHARMACEUTICALS IN NON-EUROPEAN UNION MEMBER

STATES KOSOVO, UKRAINE AND SERBIA

DR. NILESH K. PATEL

248 30-April-2019 172120824006 JETHAVA PALAKBEN NANDLALBHAI MRW403P 24 212 MPPharmaceutical


EVALUATION OF INSTABILITY ISSUE IN PAEDIATRIC DRY

SYRUP OF CEPHALOSPORIN ANTIBIOTIC IN COMBINATION

WITH CLAVULANIC ACID

DR. NILESH K. PATEL

249 30-April-2019 172120824007 KATESHIYA GOVIND AMRUTLAL MRW403P 24 212 MPPharmaceutical




NAPROXEN AND DIPHENHYDRAMINE IN K3EDTA HUMAN MR. AJAY I. PATEL

250 30-April-2019 172120824008 KHATRI AKSHALIBEN RAMCHANDRA MRW403P 24 212 MPPharmaceutical



VALIDATION FOR ESTIMATION OF DOFETILIDE IN KȝEDTA

HUMAN PLASMA BY USING LC-ESI-MS/MS

MR. AJAY I. PATEL

251 30-April-2019 172120824009 KULKARNI POOJA CHANDRAKANT MRW403P 24 212 MPPharmaceutical



VALIDATION FOR ESTIMATION OF DOSULEPIN

HYDROCHLORIDE IN KʒEDTA HUMAN PLASMA BY USING LC-

DR.AMITKUMAR J .VYAS

252 30-April-2019 172120824011 PARMAR ANKUR MOHANBHAI MRW403P 24 212 MPPharmaceutical



VALIDATION FOR ESTIMATION OF VARENICLINE TARTRATE

USING KʒEDTA HUMAN PLASMA BY LC-ESI-MS/MS

DR. ASHOK B. PATEL

253 30-April-2019 172120824015 SHARMA JIGNASHA KRUSHNAKANT MRW403P 24 212 MPPharmaceutical



VALIDATION FOR ESTIMATION OF FLUCYTOSINE IN KȝEDTA

HUMAN PLASMA BY USING LC-ESI-MS/MS

DR.AMITKUMAR J .VYAS

254 01-May-2019 172150824001 CHISTI ZENAB MOHD MASOOD MRW403P 24 215 MPPharmaceutical


HPTLC method development and validation of Naproxen

Sodium and Esomeprazole Magnesium Trihydrate in

combined dosage form.

DR. ZARNA DEDANIA

255 01-May-2019 172390824004 Madhumita Ghosh Chowdhury MRW403P 24 239 MPPharmaceutical



METHODS FOR ESTIMATION OF LIFITEGRAST IN ITS


MADHURI HINGE

256 01-May-2019 172540824004 Mandloi Nikita Rampalsingh MRW403P 24 254 MPPharmaceutical


ANALYTICAL METHODS DEVELOPMENT AND ITS

VALIDATION FOR THE ESTIMATION OF TENELIGLIPTIN

HYDROBROMIDE HYDRATE AND GLIMEPIRIDE IN

DR. SURESH KUMAR

257 01-May-2019 172650824002 DHUMAL SHRADDHA SURESH MRW403P 24 265 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR

SIMULTANEOUS ESTIMATION OF OFLOXACIN,

CLOTRIMAZOLE AND ORNIDAZOLE IN THEIR COMBINED

DR. DULENDRA P. DAMAHE

258 01-May-2019 172650824008 SINGH NEHA PRAMOD MRW403P 24 265 MPPharmaceutical



FOR SIMULTANEOUS ESTIMATION OF OFLOXACIN, DR. DULENDRA P. DAMAHE

259 02-May-2019 172050825004 PATEL ANJALIBEN BIPINBHAI MRW403P 25 205 MP Pharmacology RENAL DISORDERS

EVALUATION OF SAPONIN RICH FRACTION OF FOLK

MEDICINES FOR THE TREATMENT OF KIDNEY STONE

DISEASES

DR. TEJAL R. GANDHI

260 02-May-2019 172050825005 Patel Priyankaben Pankajbhai MRW403P 25 205 MP Pharmacology CVS DISORDER

CARDIOPROTECTIVE EFFECT OF FOENICULUM VULGARE IN

ISOPROTERENOL INDUCED MYOCARDIAL INFARCTION IN

EXPERIMENTAL RATS

DR. TEJAL R. GANDHI

261 02-May-2019 172050825006 Prajapati Riddhi Bansilal MRW403P 25 205 MP Pharmacology RENAL DISORDERS

EVALUATION OF FLAVANOID RICH FRACTION OF FOLK

MEDICINES IN EXPERIMENTALLY INDUCED UROLITHIASIS IN

RAT MODEL

DR. TEJAL R. GANDHI

262 02-May-2019 172050825007 PUROHIT MILAP DAKSHESHKUMAR MRW403P 25 205 MP Pharmacology CVS DISORDERCARDIOPROTECTIVE EFFECT OF LANSOPRAZOLE IN

EXPERIMENTALLY INDUCED CARDIAC FIBROSISDR. SARIKA JOHARI

263 02-May-2019 172050825008 SINGH ANJALI JEEVANKUMAR MRW403P 25 205 MP Pharmacology CVS DISORDEREFFECT OF SERCA2 CHANNEL MODULATOR ON DIABETIC

CARDIOMYOPATHY IN RATSDR. TEJAL R. GANDHI

264 02-May-2019 172050825009 Vaibhav Hardikbhai Shah MRW403P 25 205 MP Pharmacology CVS DISORDER

PREPARATION AND EVALUATION OF POLYHERBAL

FORMULATION FOR THE TREATMENT OF DIABETIC

CARDIOMYOPATHY

DR. TEJAL R. GANDHI

265 02-May-2019 172280825006 PURAV SUNILBHAI PATEL MRW403P 25 228 MP Pharmacology CVS DISORDEREVALUATE THE EFFECT OF TLR-4 ANTAGONIST IN

EXPERIMENTAL MODEL OF MYOCARDIAL INFARCTIONDR. ANITA A MEHTA

266 25-April-2019 172060824005 PATEL BHARGAVKUMAR PRADIPBHAI MRW403P 24 206 MPPharmaceutical



THE SIMULTANEOUS ESTIMATION OF

TRIHEXYPHENIDYL,TRIFLUOPERAZINE AND THIORIDAZINE

MRS.VANITA MARVANIYA

267 25-April-2019 172280824005 Patel Nidhi Tikendrabhai MRW403P 24 228 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC

METHOD FOR SIMULTANEOUS ESTIMATION OF

OFLOXACIN, TINIDAZOLE, TERBINAFINE HYDROCHLORIDE

DR. KUNJAN BODIWALA

268 25-April-2019 172280824008 SHARMA PRIYANKA KAMLESHBHAI MRW403P 24 228 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF A STABILITY

INDICATING HPTLC METHOD FOR TENELIGLIPTIN AND

METFORMIN.

DR. MAHESH T. CHHABRIA

269 25-April-2019 172620824003 HIMANI RAJESHKUMAR SAVANI MRW403P 24 262 MPPharmaceutical



FOR SIMULTANEOUS ESTIMATION OF SIMVASTATIN AND

PIOGLITAZONE HYDROCHLORIDE IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

270 25-April-2019 172620824004 MOURYA POONAM GHANSHYAMBHAI MRW403P 24 262 MPPharmaceutical



FOR SIMULTANEOUS ESTIMATION OF LISINOPRIL AND

LOSARTAN POTASSIUM IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

271 25-April-2019 172620824008 PATEL DIVYABEN VIRCHANDBHAI MRW403P 24 262 MPPharmaceutical


METHOD DEVELOPMENT AND VALIDATION OF LEVODOPA

AND BENSERAZIDE IN ORAL DISPERSIBLE TABLET BY RP-

HPLC METHOD

DR JITENDRA O. BHANGALE

272 25-April-2019 172620824010 Saini Ravi bhanwarlal MRW403P 24 262 MPPharmaceutical



FOR SIMULTANEOUS ESTIMATION OF VILDAGLIPTIN AND

NATEGLINIDE IN SYNTHETIC MIXTURE

DR JITENDRA O. BHANGALE

273 25-April-2019 172620824012 TRIVEDI FORAM DHARMENDRABHAI MRW403P 24 262 MPPharmaceutical



FOR SIMULTANEOUS ESTIMATION OF NEBIVOLOL

HYDROCHLORIDE AND LISINOPRIL IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

274 26-April-2019 172250824001 Dhruv Nikita Mahendrakumar MRW403P 24 225 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR

SIMULTANEOUS ESTIMATION OF BENIDIPINE HCL,

TELMISARTAN AND CHLORTHALIDONE IN TABLET DOSAGE

DR. DEEPA R. PATEL

275 26-April-2019 172250824005 PANCHAL HINABEN HASUBHAI MRW403P 24 225 MPPharmaceutical


METHOD DEVELOPMENT AND VALIDATION FOR

SIMULTANEOUS ESTIMATION OF TRIHEXYPHENIDYL,

THIORIDAZINE AND TRIFLUOPERAZINE IN ITS

DR. DEEPA R. PATEL

276 26-April-2019 172420824001 BAGHEL LAXMI SHIVNARAYANSINGH MRW403P 24 242 MPPharmaceutical


DOCUMENTATION IN QUALITY MANAGEMENT SYSTEM

(QMS) AND DATA INTEGRITY IN PHARMACEUTICAL

INDUSTRY

MS. JIGNA T. PATEL

277 26-April-2019 172420824004 PATEL MINALBEN VINODBHAI MRW403P 24 242 MPPharmaceutical


A COMPREHENSIVE AND COMPARATIVE STUDY ON

REGULATIONS OF MEDICAL COUNTERMEASURES IN USA,

EUROPE AND INDIA


278 26-April-2019 172600824005 PATEL AISHWARYA JITENDRA MRW403P 24 260 MPPharmaceutical

Quality AssuranceDISSOLUTION STUDIES

DEVELOPMENT AND VALIDATION OF DISSOLUTION TEST

METHOD FOR FLUNARIZINE, DOMPERIDONE AND

PARACETAMOL IN PHARMACEUTICAL DOSAGE FORM

DR. CHIRAG J. PATEL

279 26-April-2019 172780824006 PUJARA DISHA KIRITKUMAR MRW403P 24 278 MPPharmaceutical



VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF

AMBROXOL HYDROCHLORIDE AND GUAIFENESIN IN

HUMAN PLASMA BY USING LC-MS/MS

DR KINJAL SOLANKI

280 26-April-2019 172780824008 THAKKAR BHOOMIBEN HASMUKHBHAI MRW403P 24 278 MPPharmaceutical


BIO ANALYTICAL METHOD DEVELOPMENT AND

VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF

SOFOSBUVIR AND LEDIPASVIR IN HUMAN PLASMA BY LC-

DR RAJESH K PATEL

281 26-April-2019 162560804005 PATEL DHAVAL SURESHBHAI 940104 04 256 MPQUALITY

ASSURANCESIMULTENEOUS ESTIMATION

DEVELOPMENT AND VALIDATION OF UV AND RP-HPLC

METHOD FOR SIMULTANEOUS ESTIMATION OF

SAQUINAVIR DRUG IN BULK AND PHARMACEUTICAL

DR. BIRAJUBEN PATEL

282 29-April-2019 172150827001 BHANDARI KRISHNA KAUSHIKKUMAR MRW403P 27 215 MPPharmaceutical

Regulatory AffairsREGULATORY AFFAIRS

CURRENT REGULATORY REQUIREMENT FOR EXPORT OF

SOLID ORAL DOSAGE FORM IN BRAZIL AND MEXICODR .VINEET JAIN

283 29-April-2019 172150827002 Chaudhary Reena Bhagawanswaroop MRW403P 27 215 MPPharmaceutical


GUIDELINES AND REGULATORY REQUIREMENTS FOR

LABELLING AND PACKAGING OF INJECTIONS IN USA,

EUROPE, INDIA AND CANADA.

DR. RONAK DEDANIA

284 29-April-2019 172880827001 Ansari Daraksha Muhammad MRW403P 27 288 MPPharmaceutical


A STUDY ON REGISTRATION PROCESS FOR MOISTURIZING

CREAM AND ANTI-ACNE CREAM IN INDIA, USA, EUROPEAN MR. FENIL SHAH

285 29-April-2019 172880827002 BATADA NORIN BARKATBHAI MRW403P 27 288 MPPharmaceutical


COMPARISON OF REGULATORY REQUIREMENTS AS PER

USFDA & EMA FOR IMMEDIATE RELEASE AND EXTENDED MR. NAGESH NANDA

286 29-April-2019 172880827004 GANDHI HANSAL VIJAY MRW403P 27 288 MPPharmaceutical


A STUDY ON REGISTRATION PROCESS OF GENERIC

BUDESONIDE DRY POWDER INHALER AS PER USFDA

GUIDANCE

DR. RAJESH PARIKH

287 30-April-2019 172020822001 TARAPRA ANKITABEN MOHANBHAI MRW403P 22 202 MPPharmaceutical

ChemistryOTHER (KINDLY SPECIFY)

DESIGN, SYNTHESIS AND ANTI-ALZHEIMER ACTIVITY OF

NOVEL CHROMAN DERIVATIVESDR. VIPUL VAGHELA

288 30-April-2019 172540822004 PATEL SAMEERA SULEMAN MRW403P 22 254 MPPharmaceutical

ChemistryMEDICINAL CHEMISTRY

SYNTHESIS AND EVALUATION OF NEW 7-HYDROXY

COUMARIN DERIVATIVES AS ANTI- ALZHEIMER AGENTSDR. MORE UTTAM

289 02-May-2019 172280825001 BHOOMIT MAHENDRABHAI PATEL MRW403P 25 228 MP Pharmacology CANCEREFFECT OF DISULFIRAM AND CAFFEINE ON NSCLC

RESISTANCE TO GEMCITABINE AND CISPLATINDR. SUNITA GOSWAMI

290 02-May-2019 172280825007 Sangtani Kajol Haresh MRW403P 25 228 MP Pharmacology CNS DISORDER

ASSESSMENT OF THE RELATIONSHIP BETWEEN

ANTIDEPRESSANT AND COGNITION IMPROVING ABILITIES

OF SHANKHPUSHPI AND ASHWAGANDHA EXTRACTS IN

DR. SUNITA GOSWAMI

291 02-May-2019 172280825008 Suthar Hiran Nilesh MRW403P 25 228 MP Pharmacology CNS DISORDER

EVALUATION OF WITHANIA SOMNIFERA AND

CONVULVULUS PLURICAULIS (CHOISY) ON VARIOUS

DOMAINS OF COGNITION IMPAIRED IN SUB-CHRONIC

DR. GAURANG B. SHAH

292 02-May-2019 172680825004 PATEL SHITALBEN RAJUBHAI MRW403P 25 268 MP PharmacologyG.I. TRACT ( PLEASE SPECIFY

DISORDER OR DISEASE)

EFFECT OF COMBINED EXTRACT OF CORDIA DICHOTOMA

FORST. AND AEGLE MARMELOS CORR. IN EXPERIMENTAL

MODELS OF PEPTIC ULCER

DR. VIJAY LAMBOLE

293 25-April-2019 172060824007 PATEL YASH KANUBHAI MRW403P 24 206 MPPharmaceutical



VALIDATION FOR ESTIMATION OF FORMOTEROL IN

HUMAN PLASMA BY LC-MS/MS.

MRS.VANITA MARVANIYA

294 25-April-2019 172600824001 BAMBHROLIYA VIREN GHANSHYAMBHAI MRW403P 24 260 MPPharmaceutical



VALIDATION FOR ESTIMATION OF FLUTICASONE IN DR. CHIRAG J. PATEL

295 25-April-2019 172620824006 PATEL BINAL NARESHBHAI MRW403P 24 262 MPPharmaceutical



FOR IMPURITY PROFILE OF CITICOLINE SODIUM IN TABLET

DOSAGE FORM

DR. JITENDRA O.

BHANGALE

296 25-April-2019 172860824001 kunal Bhatt MRW403P 24 286 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF BIOANALYTICAL

METHOD FOR DETERMINATION OF CLOMIPRAMINE AND N-

DESMETHYL CLOMIPRAMINE FROM K3 EDTA HUMAN

DR. MANDEV B. PATEL

297 25-April-2019 172860824002 Kuntalkumar maheshbhai prajapati MRW403P 24 286 MPPharmaceutical



METHOD FOR DETERMINATION OF AMBRISENTAN FROM

K3 EDTA HUMAN PLASMA USING LC-MS/MS.

DR. MANDEV B. PATEL

298 25-April-2019 172860824007 Prajapati Kinnari Dasharathbhai MRW403P 24 286 MPPharmaceutical



MEHTHOD FOR DETERMINATION OF DEFERASIROX FROM

HUMAN PLASMA USING LC-MS/MS.

MS. MINAKSHI DHORU

299 25-April-2019 172860824009 Shah Kajal Rajendrabhai MRW403P 24 286 MPPharmaceutical



METHOD FOR DETERMINATION OF EXEMESTANE FROM K3

EDTA HUMAN PLASMA USING LC-MS/MS

MS. MINAKSHI DHORU

300 25-April-2019 172860824014 vikas pal MRW403P 24 286 MPPharmaceutical



METHODS FOR DETERMINATION OF PROPAFENONE AND 5-

HYDROXYPROPAFENONE FROM K3 EDTA HUMAN PLASMA

DR. MANDEV B. PATEL

301 26-April-2019 172280824003 HAPPY PARIN PATEL MRW403P 24 228 MPPharmaceutical



INDICATING CHROMATOGRAPHIC METHOD FOR

ESTIMATION OF ALFUZOSIN HYDROCHLORIDE AND

DR. SINDHU EZHAVA

302 26-April-2019 172780824003 KHATRI HEMAXI DEVENDRAKUMAR MRW403P 24 278 MPPharmaceutical


ANNUAL PRODUCT QUALITY REVIEW (APQR) OF LOSARTAN

TABLETS 100 MGDR VIKRAM PANDYA

303 26-April-2019 172860824005 Pandya Shivangi Krupeshchandra MRW403P 24 286 MPPharmaceutical



METHODS FOR DETERMINATION OF DILTIAZEM MALEATE

AND ENALAPRIL MALEATE FROM ITS FIXED DOSE

DR. PINAK R. PATEL

304 26-April-2019 172860824011 Shukla Rashmi Rammilan MRW403P 24 286 MPPharmaceutical



METHODS FOR DETERMINATION OF RIVAROXABAN AND

ASPIRIN FROM SYNTHETIC MIXTURE.

DR. PINAK R. PATEL

305 26-April-2019 172860824012 Sirsiker bhumi prashantbhai MRW403P 24 286 MPPharmaceutical



METHODS FOR DETERMINATION OF TOBRAMYCIN AND

FLUOROMETHOLONE ACETATE FROM OPTHALMIC

FORMULATION

DR. PINAK R. PATEL

306 26-April-2019 162520804003 PATEL JALAK VINUBHAI 940104 04 252 MPQUALITY

ASSURANCESTABILITY STUDIES


INDICATING HPLC METHOD FOR SIMULTANEOUS

ESTIMATION OF BENIDIPINE HCI AND CHLORTHALIDONE IN

TABLET

MR M L KHARODIYA

307 29-April-2019 172150827003 Dobariya Janki Rasikkumar MRW403P 27 215 MPPharmaceutical

Regulatory AffairsSIMULTENEOUS ESTIMATION

A COMPREHENSIVE STUDY ON REGULATORY

REQUIREMENTS FOR PRODUCT REGISTRATION OF

VACCINES IN USA, EUROPE AND CANADA.

DR. RONAK DEDANIA

308 29-April-2019 172150827004 Juneja Parul jitender MRW403P 27 215 MPPharmaceutical


REGULATORY GUIDELINES OF HAZARD ANALYSIS CRITICAL

CONTROL POINT (HACCP) WITH COMPREHENSIVE STUDY

ON STANDARDS AND CERTIFICATION PROCEDURES IN USA,

DR. RONAK DEDANIA

309 29-April-2019 172150827005 MAHLA SWETA MAVJIBHAI MRW403P 27 215 MPPharmaceutical


A COMPARATIVE STUDY OF REGULATORY REQUIREMENTS

AND GUIDELINES FOR MEDICAL DEVICES IN USA,JAPAN

AND CANADA

DR. RONAK DEDANIA

310 29-April-2019 172150827008 TAILOR BRINDA ASHISHKUMAR MRW403P 27 215 MPPharmaceutical


CURRENT STATUS OF GENERIC DRUG APPROVAL PROCESS

IN UNITED STATES OF AMERICA AND EUROPEAN UNIONDR .VINEET JAIN

311 29-April-2019 172150827009YADAV KUSUM KUMARI SHREE DINESH

KUMARMRW403P 27 215 MP

Pharmaceutical


NAVIGATING REGULATORY FRAMEWORK TO DEFEAT ZIKA

VIRUS IN USA AND EUDR .VINEET JAIN

312 30-April-2019 172540822001 DHARASANDIYA ARZOO PRABHUDAS MRW403P 22 254 MPPharmaceutical

Chemistry

MEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW BRIDGEHEAD NITROGEN

HETEROCYCLES AS POTENTIAL ANTICANCER AGENTSDR. M. N. NOOLVI

313 30-April-2019 172540822002 JOSHI NIDHIBEN BHASKARBHAI MRW403P 22 254 MPPharmaceutical

Chemistry

MEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW QUINAZOLINE DERIVATIVES AS

ANTICANCER AGENTSMS. MONIKA KAKADIYA

314 30-April-2019 172540822003 MOGAL AZMIN MAHERVAN MRW403P 22 254 MPPharmaceutical

Chemistry

MEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW TAMOXIFEN ANALOGUES AS

POTENTIAL ANTICANCER AGENTSDR. M. N. NOOLVI

315 30-April-2019 172540822005 PATEL ZOFINA IKBAL MRW403P 22 254 MPPharmaceutical

Chemistry

MEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW CANTHARIDIN DERIVATIVES AS


316 30-April-2019 172540822007 Rahevar Vidhikumari Bhupeshkumar MRW403P 22 254 MPPharmaceutical


SYNTHESIS AND EVALUATION OF NEW FLAVONOID

DERIVATIVES AS ANTI-ALZHEIMER AGENTSDR. MORE UTTAM

317 30-April-2019 172540822008 SINGH RAMIYA TILAKDHARI MRW403P 22 254 MPPharmaceutical


SYNTHESIS OF NEW QUINOLINE DERIVATIVES AS

ANTITUBERCULAR AGENTSMS. MONIKA KAKADIYA

318 30-April-2019 172540822009 Zalavadiya Vivek Sureshbhai MRW403P 22 254 MPPharmaceutical

Chemistry

MEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW CHROMAN-4-ONE DERIVATIVES AS


319 25-April-2019 172060824011 VAGHELA AKSHAY PRAVINBHAI MRW403P 24 206 MPPharmaceutical



VALIDATION FOR SIMULTANEOUS DETERMINATION OF

IBUPROFEN AND HYDROCODONE BITARTRATE IN THEIR

COMBINED DOSAGE FORM

DR. NEHA TIWARI

320 25-April-2019 172080824002 PARMAR MONIKA JAGDISHBHAI MRW403P 24 208 MPPharmaceutical



AND VALIDATION OF S(-) AMLODIPINE BESYLATE AND

HYDROCHLOROTHIAZIDE IN BULK AND PHARMACEUTICAL

MR HIREN KADIKAR

321 25-April-2019 172080824003 PATEL BHOOMIKA VINODBHAI MRW403P 24 208 MPPharmaceutical



AND VALIDATION OF DOLUTEGRAVIR, LAMIVUDINE AND

TENOFOVIR DISOPROXIL FUMARATE IN ITS COMBINED

DOSAGE FORM

MS MONA KAUSHAL

322 25-April-2019 172080824005 SAIYAD ANISH MIRSHABMIYA MRW403P 24 208 MPPharmaceutical


STABILITY INDICATING METHOD DEVELOPMENT AND


EMTRICITABINE AND TENOFOVIR ALAFENAMIDE IN TABLET

DR JITENDRA PATEL

323 25-April-2019 172600824004 PANCHAL SHIVANI HITESHKUMAR MRW403P 24 260 MPPharmaceutical



INDICATING ASSAY METHOD FOR ESTIMATION OF

TOFACITINIB IN TOFACITINIB CITRATE IMMEDIATE RELEASE

TABLET DOSAGE FORM

DR. CHIRAG J. PATEL

324 25-April-2019 172600824006 PATEL DIMPLE NATVARLAL MRW403P 24 260 MPPharmaceutical


METHOD DEVELOPMENT AND VALIDATION BY

CHROMATOGRAPHIC METHOD FOR DETERMINATION OF

ERYTHROMYCIN IN PHARMACEUTICAL DOSAGE FORM

DR. CHIRAG J. PATEL

325 25-April-2019 172860824003 MAKWANA HEMANGIBEN SHASHIKANT MRW403P 24 286 MPPharmaceutical



INDICATING RP-HPLC METHOD FOR DETERMINATION OF

EFONIDIPINE HYDROCHLORIDE ETHANOLATE IN BULK AND

MRS. BINNY D. MEHTA

326 25-April-2019 172860824008 sangale Hemangi Shivji MRW403P 24 286 MPPharmaceutical



INDICATING RP-HPLC METHOD FOR DETERMINATION OF

MIRABEGRON FROM ITS PHARMACEUTICAL

FORMULATION

MRS. BINNY D. MEHTA

327 26-April-2019 172250824003 JAIN JUHI ANILKUMAR MRW403P 24 225 MPPharmaceutical



DEVELOPMENT AND VALIDATION OF BENIDIPINE

HYDROCHLORIDE AND CHLORTHALIDONE IN TABLET

DR. DEEPA R. PATEL

328 26-April-2019 172280824006 Shah Jaldhi Hemantbhai MRW403P 24 228 MPPharmaceutical



INDICATING METHOD FOR ESTIMATION OF

DAPAGLIFLOZIN AND ITS APPLICATION TO STUDY

DR. KUNJAN BODIWALA

329 26-April-2019 172470824013 Salunkhe Suchitra Sunil MRW403P 24 247 MPPharmaceutical


PROCESS VALIDATION OF RIFAMPICIN AND ISONIAZID FILM

COATED TABLETSMR.JAYMIN G. PATEL

330 26-April-2019 172470824014 VAGH VIRAL VITTHALBHAI MRW403P 24 247 MPPharmaceutical


PROCESS OPTIMIZATION AND PROCESS VALIDATION OF

MYOINOSITOL AND D-CHIRO INOSITOL FILM COATED

TABLET

MS. BHUMI R. PATEL

331 26-April-2019 162470804013 patel nikita mahendrabhai 940104 04 247 MPQUALITY

ASSURANCE

STABILITY INDICATING RP-HPLC METHOD METHOD

DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS

ESTIMATION OF TICLOPIDINE AND ASPIRIN IN ITS

Mr.Jaymin G.Patel

332 26-April-2019 172600824007 THAKKER KRINA SURESHKUMAR MRW403P 24 260 MPPharmaceutical


PROCESS VALIDATION OF OPTIMIZED FORMULATION OF

VENLAFAXINE HYDROCHLORIDE 37.5 MG TABLET DOSAGE

FORM

DR. CHIRAG J. PATEL

333 26-April-2019 172860824013 Vasani Priyanka sureshbhai MRW403P 24 286 MPPharmaceutical



METHODS FOR DETERMINATION OF PAMABROM AND

NSAIDs IN COMBINATION

DR. PINAK R. PATEL

334 29-April-2019 172880827005 GOHEL SAGAR KISHORBHAI MRW403P 27 288 MPPharmaceutical


A STUDY ON SUMMARY TECHNICAL DOCUMENTATION

(STED) FOR TRANSCATHETER SEPTAL OCCLUDER AS PER

INTERNATIONAL MEDICAL DEVICE REGULATORS FORUM

DR. ANAND SHAH

335 29-April-2019 172880827006 JADAV RAHUL KIRITKUMAR MRW403P 27 288 MPPharmaceutical


A STUDY ON REGULATORY REQUIREMENTS TO PREVENT

COUNTERFEIT DRUGS IN USA, EUROPE & INDIAMR. NIRAV CHOKSHI

336 29-April-2019 172880827007 JAGANI DHARMESHKUMAR UKABHAI MRW403P 27 288 MPPharmaceutical


PREPARATION OF DRAFT ABBREVIATED NEW DRUG

APPLICATION (ANDA) FOR OSELTAMIVIR CAPSULE AS PER DR. ANAD SHAH

337 29-April-2019 172880827008 PATEL PANKTIBEN KIRTIKUMAR MRW403P 27 288 MPPharmaceutical


COMPARISON OF REGULATORY REQUIREMENTS AS PER

USFDA & EMA FOR DELAYED RELEASE AND EXTENDED

RELEASE ORAL FORMULATIONS AND COMPILATION OF

MR. KASHYAP THUMMAR

338 29-April-2019 172880827009 PATEL YAGNESHKUMAR VINODBHAI MRW403P 27 288 MPPharmaceutical


A STUDY ON REGISTRATION PROCESS OF RITUXIMAB

INJECTION -A BIOSIMILAR PRODUCT TO MabThera® AS PER

EMA

MR. FENIL SHAH

339 29-April-2019 172880827010 Shipra Vijayesh Pandey MRW403P 27 288 MPPharmaceutical


NALOXONE HCL NASAL SPRAY : DRAFT DOSSIER

PREPARATION FOR ANDS AS PER HEALTH CANADADR. ANAND SHAH

340 29-April-2019 172880827011 THAKKAR RAGHAV ATMARAMBHAI MRW403P 27 288 MPPharmaceutical


REGULATORY CONSIDERATION FOR IMPORT &

REGISTRATION OF HEMODIALYSER IN INDIA & EXPORT IN

MEMBER COUNTRIES OF ASEAN

MR. KASHYAP THUMMAR

Student list for M.Pharm Sem 4 (Regular) Dissertation Phase ...

Documents

Transcript of Student list for M.Pharm Sem 4 (Regular) Dissertation Phase ...